Andreas G. Tzakis

Andreas G. Tzakis's AcademicInfluence.com Rankings

Andreas G. Tzakis

Medical

#1362

World Rank

#1690

Historical Rank

Surgery

#104

World Rank

#144

Historical Rank

medical Degrees

Andreas G. Tzakis

Philosophy

#4373

World Rank

#6861

Historical Rank

Logic

#1844

World Rank

#2697

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Andreas G. Tzakis Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Andreas G. Tzakis's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance (1993) (808)
Hepatic resection versus transplantation for hepatocellular carcinoma. (1991) (621)
Orthotopic liver transplantation with preservation of the inferior vena cava. (1989) (565)
Infections after Liver Transplantation: AN ANALYSIS OF 101 CONSECUTIVE CASES (1988) (485)
The Incidence, Timing, and Management of Biliary Tract Complications After Orthotopic Liver Transplantation (1994) (467)
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation (1997) (458)
2003 Report of the Intestine Transplant Registry: A New Era Has Dawned (2005) (441)
The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. (1995) (435)
Islet isolation assessment in man and large animals (1990) (422)
CLINICAL PRESENTATION OF HEPATIC ARTERY THROMBOSIS AFTER LIVER TRANSPLANTATION IN THE CYCLOSPORINE ERA (1985) (397)
First clinical uterus transplantation trial: a six-month report. (2014) (347)
Primary nonfunction of hepatic allografts with preexisting fatty infiltration. (1989) (333)
Baboon-to-human liver transplantation (1993) (331)
Indications for pediatric intestinal transplantation: A position paper of the American Society of Transplantation (2001) (331)
Transplantation of the abdominal wall (2003) (315)
Transplantation of multiple abdominal viscera. (1989) (310)
Complications of Venous Reconstruction in Human Orthotopic Liver Transplantation (1987) (305)
Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation (1994) (278)
HUMAN ISLET ISOLATION AND ALLOTRANSPLANTATION IN 22 CONSECUTIVE CASES 1, 2 (1992) (257)
Outcome Analysis of 71 Clinical Intestinal Transplantations (1995) (255)
BILIARY TRACT COMPLICATIONS IN HUMAN ORTHOTOPIC LIVER TRANSPLANTATION (1987) (249)
Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. (2001) (247)
Orthotopic liver transplantation for alcoholic cirrhosis. (1988) (245)
Pancreatic islet transplantation after upper abdominal exeriteration and liver replacement (1990) (243)
Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis (1988) (243)
Abdominal Organ Cluster Transplantation for the Treatment of Upper Abdominal Malignancies (1989) (240)
Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. (1997) (238)
The spectrum of portal vein thrombosis in liver transplantation. (1991) (231)
Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. (1988) (228)
Liver, Kidney, and Thoracic Organ Transplantation Under FK 506 (1990) (224)
Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event? (1989) (220)
A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1 (2005) (217)
Kidney transplantation under FK 506. (1990) (216)
Intestinal transplantation in composite visceral grafts or alone. (1992) (212)
Effect of donor age and sex on the outcome of liver transplantation. (1995) (209)
Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. (1988) (204)
100 Multivisceral Transplants at a Single Center (2005) (199)
Neurologic complications of FK 506. (1991) (196)
Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation. (1999) (191)
Adverse effects associated with the use of FK 506. (1991) (190)
The many faces of multivisceral transplantation. (1991) (185)
Transplantation in HIV+ patients. (1990) (178)
Nutritional support after liver transplantation: a randomized prospective study. (1990) (178)
Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. (1987) (173)
Liver transplantation with cavoportal hemitransposition in the presence of diffuse portal vein thrombosis. (1998) (166)
Cholangiographic findings in hepatic artery occlusion after liver transplantation. (1987) (166)
Orthotopic liver transplantation in patients with human immunodeficiency virus and end‐stage liver disease (2003) (161)
Liver transplantation in the treatment of bleeding esophageal varices. (1988) (160)
Obesity as a risk factor following cadaveric renal transplantation. (1990) (157)
Negative Impact of New-Onset Diabetes Mellitus on Patient and Graft Survival After Liver Transplantation: Long-Term Follow Up (2006) (156)
Benign and Solid Tumors of the Liver: Relationship to Sex, Age, Size of Tumors, and Outcome (2001) (156)
Assessment of five-year experience with abdominal organ cluster transplantation. (1995) (153)
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. (1991) (152)
Replacement of donor lymphoid tissue in small-bowel transplants (1991) (152)
The antibody crossmatch in liver transplantation. (1986) (151)
Weaning Of Immunosuppression In Long‐Term Liver Transplant Recipients (1995) (150)
CADAVERIC SMALL BOWEL AND SMALL BOWEL‐LIVER TRANSPLANTATION IN HUMANS 1,2 (1992) (149)
Liver transplantation across ABO blood groups. (1986) (148)
High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing. (1997) (142)
STUDIES OF PEDIATRIC LIVER TRANSPLANTATION (SPLIT): YEAR 2000 OUTCOMES (2001) (141)
FK506 “RESCUE” FOR RESISTANT REJECTION OF RENAL ALLOGRAFTS UNDER PRIMARY CYCLOSPORINE IMMUNOSUPPRESSION1 (1994) (139)
Three years clinical experience with intestinal transplantation. (1994) (137)
FK 506 in clinical kidney transplantation. (1991) (131)
Liver biopsy. Its safety and complications as seen at a liver transplant center. (1993) (129)
When and Why Portal Vein Thrombosis Matters in Liver Transplantation: A Critical Audit of 174 Cases (2014) (127)
SIX-YEAR CLINICAL EFFECT OF DONOR BONE MARROW INFUSIONS IN RENAL TRANSPLANT PATIENTS1 (2001) (125)
Ninety-five cases of intestinal transplantation at the university of Miami (2001) (125)
A Retrospective Review of Liver Transplant Patients Treated with Sirolimus from a Single Center: An Analysis of Sirolimus-Related Complications (2004) (123)
Intestinal and Multivisceral Transplantation in Children (2006) (123)
Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis (1990) (121)
The Use of Campath-1H as Induction Therapy in Renal Transplantation: Preliminary Results (2004) (121)
Treatment of Established Recurrent Hepatitis C in Liver-Transplant Recipients with Pegylated Interferon-alfa-2b and Ribavirin Therapy (2004) (119)
THE ADVERSE IMPACT ON LIVER TRANSPLANTATION OF USING POSITIVE CYTOTOXIC CROSSMATCH DONORS 1, 2 (1992) (118)
Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation (2004) (117)
Hepatic artery in liver transplantation. (1987) (116)
Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. (1989) (115)
The Role of Donor Bone Marrow Infusions in Withdrawal of Immunosuppression in Adult Liver Allotransplantation (2005) (115)
WEANING OF IMMUNOSUPPRESSION IN LONG-TERM LIVER TRANSPLANT RECIPIENTS (1995) (114)
Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. (1988) (112)
PRELIMINARY EXPERIENCE WITH ALEMTUZUMAB (CAMPATH-1H) AND LOW-DOSE TACROLIMUS IMMUNOSUPPRESSION IN ADULT LIVER TRANSPLANTATION (2004) (111)
Percutaneous transluminal angioplasty of venous anastomotic stenoses complicating liver transplantation: intermediate-term results. (1994) (111)
Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. (1989) (110)
SMALL INTESTINAL TRANSPLANTATION IN HUMANS WITH OR WITHOUT THE COLON1,2 (1994) (108)
In vivo effect of FK506 on human pancreatic islets. (1991) (107)
Liver transplantation for polycystic liver disease. (1990) (105)
Childbearing after liver transplantation. (1990) (105)
Is Surgical Resection Superior to Transplantation in the Treatment of Hepatocellular Carcinoma? (2011) (105)
Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. (1992) (103)
Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C? (1992) (102)
Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation. (1998) (102)
Uterus transplantation: animal research and human possibilities. (2012) (102)
Endotoxemia and human liver transplantation. (1989) (99)
A Comparison of Tacrolimus and Cyclosporine in Liver Transplantation: Effects on Renal Function and Cardiovascular Risk Status (2005) (99)
Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation1 (2003) (99)
Venous jump grafts for liver transplantation in patients with portal vein thrombosis. (1989) (96)
Frequent achievement of a drug-free state after orthotopic liver transplantation. (1993) (96)
Transplantation for primary biliary cirrhosis. (1988) (93)
Intrahepatic biliary strictures after liver transplantation. (2006) (91)
Liver transplantation for Alagille's syndrome. (1993) (89)
ENDOTOXAEMIA, PULMONARY COMPLICATIONS, AND THROMBOCYTOPENIA IN LIVER TRANSPLANTATION (1989) (89)
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. (1991) (88)
Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. (1989) (88)
Current status of transplantation of the small intestine. (2007) (88)
Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. (1988) (88)
The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. (1997) (87)
Analysis of surgical complications after 397 hepatic transplantations. (1990) (87)
Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation. (1998) (86)
The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. (1998) (86)
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. (1991) (85)
Preclinical report on allogeneic uterus transplantation in non-human primates. (2013) (85)
Vascular complications, treatment, and outcome following orthotopic liver transplantation. (1997) (85)
Current status of intestinal transplantation. (1994) (85)
Liver transplantation in patients with previous portasystemic shunt. (1990) (84)
Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome. (1993) (84)
Graft-Versus-Host Disease After Intestinal and Multivisceral Transplantation (2011) (83)
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. (1994) (83)
Effect of protocol Doppler ultrasonography and urgent revascularization on early hepatic artery thrombosis after pediatric liver transplantation. (2002) (83)
Liver transplantation in patients over sixty years of age. (2001) (83)
Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation (2003) (83)
Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation (1994) (82)
Intestinal and Multivisceral Transplantation (2002) (82)
Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine (2003) (82)
A multifactorial system for equitable selection of cadaver kidney recipients. (1987) (81)
Liver transplantation for type IV glycogen storage disease. (1991) (81)
Selective decontamination in pediatric liver transplants. A randomized prospective study. (1993) (81)
Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients (2002) (81)
Heterotopic Uterus Transplantation in a Swine Model (2009) (80)
Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation (1999) (79)
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. (1995) (78)
Use of the Abdominal Rectus Fascia as a Nonvascularized Allograft for Abdominal Wall Closure After Liver, Intestinal, and Multivisceral Transplantation (2009) (78)
Liver transplantation with renoportal anastomosis after distal splenorenal shunt. (2000) (77)
Randomized Trial of Steroid-Free Induction Versus Corticosteroid Maintenance Among Orthotopic Liver Transplant Recipients With Hepatitis C Virus: Impact on Hepatic Fibrosis Progression at One Year (2007) (76)
Reversal of hypersplenism following orthotopic liver transplantation. (1989) (75)
Does the Heterozygous State of Alpha-1 Antitrypsin Deficiency Have a Role in Chronic Liver Diseases? Interim Results of a Large Case-Control Study (2006) (75)
Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy. (1997) (75)
Ten years of sirolimus therapy in orthotopic liver transplant recipients. (2003) (74)
Kidney transplantation under FK 506 immunosuppression. (1991) (73)
Liver and Intestine Transplantation in the United States, 1995–2004 (2006) (73)
Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease (2009) (72)
Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients. (1998) (71)
Abdominal Multivisceral Transplantation (1995) (71)
A New Technique for Isolating and Culturing Human Hepatocytes from Whole or Split Livers not Used for Transplantation (1994) (71)
Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. (1993) (70)
Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. (1991) (68)
Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection (2004) (67)
Course of enterovesical fistulas in Crohn's disease. (1984) (66)
Serum citrulline and rejection in small bowel transplantation: a preliminary report. (2001) (66)
Deceased Donor Uterine Transplantation: Innovation and Adaptation. (2016) (65)
Indications for pediatric liver transplantation. (1987) (65)
Occurrence of cytomegalovirus hepatitis in liver transplant patients (1988) (65)
Use of older controlled non-heart-beating donors for liver transplantation (2003) (65)
Logistics and technique for combined hepatic-intestinal retrieval. (1992) (65)
Analysis of Acute Cellular Rejection Episodes in Recipients of Primary Intestinal Transplantation: A Single Center, 11‐Year Experience (2007) (64)
HEPATIC ARTERY PSEUDOANEURYSM LIGATION AFTER ORTHOTOPIC LIVER TRANSPLANTATION—A REPORT OF 7 CASES (1992) (64)
An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry. (1996) (64)
Bacterial infections after intestine and multivisceral transplantation. (2003) (63)
PARVOVIRUS B19 INFECTION IN PEDIATRIC TRANSPLANT PATIENTS (1993) (63)
Tenofovir Therapy for Lamivudine Resistance Following Liver Transplantation (2004) (63)
Adenovirus Infection in Pediatric Liver and Intestinal Transplant Recipients: Utility of DNA Detection by PCR (2003) (63)
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. (1991) (63)
Hepatic artery reconstruction for hepatic artery thrombosis after orthotopic liver transplantation. (1990) (63)
Liver transplantation in patients with patent splenorenal shunts. (1987) (62)
Inclusion of Donor Colon and Ileocecal Valve in Intestinal Transplantation (2008) (62)
Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement. (1999) (62)
Outcomes After Orthotopic Liver Transplantation in 15 HIV-Infected Patients (2007) (62)
Intestinal transplantation in children: A summary of clinical outcomes and prognostic factors in 108 patients from a single center (2007) (61)
Piggyback technique in adult orthotopic liver transplantation: an analysis of 1067 liver transplants at a single center. (2006) (60)
Liver transplantation for the Budd-Chiari syndrome. (1976) (60)
The dearterialized liver graft. (1985) (59)
Temporary end to side portacaval shunt in orthotopic hepatic transplantation in humans. (1993) (59)
Transplantation of the Spleen: Effect of Splenic Allograft in Human Multivisceral Transplantation (2007) (59)
First birth from a deceased donor uterus in the United States: from severe graft rejection to successful cesarean delivery. (2020) (58)
Intestinal and multivisceral transplantation in children with severe gastrointestinal dysmotility. (2005) (58)
Prospects of clinical xenotransplantation. (1994) (58)
Intrahepatic Biliary Strictures without Hepatic Artery Thrombosis after Liver Transplantation: An Analysis of 1,113 Liver Transplantations at a Single Center (2005) (58)
Mucosal Vascular Alterations in Isolated Small‐Bowel Allografts: Relationship to Humoral Sensitization (2003) (57)
Expanded use of transplantation techniques: abdominal wall transplantation and intestinal autotransplantation. (2004) (57)
Pancreatic islet transplantation (1990) (57)
Blood Citrulline Level Is an Exclusionary Marker for Significant Acute Rejection After Intestinal Transplantation (2007) (55)
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. (1991) (54)
The Pathology of Full-thickness Cadaver Skin Transplant for Large Abdominal Defects: A Proposed Grading System for Skin Allograft Acute Rejection (2004) (54)
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. (1991) (54)
Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow. (2004) (54)
Recurrent Crohn's disease in transplanted bowel (1997) (54)
Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review. (1991) (54)
Liver transplantation for fulminant hepatic failure. (1985) (54)
Liver transplantation: an unfinished product. (1989) (53)
Deceased donor uterine transplantation. (2017) (52)
Serum citrulline as a marker of acute cellular rejection for intestinal transplantation. (2002) (52)
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. (1991) (52)
DONOR BONE MARROW-DERIVED CHIMERIC CELLS PRESENT IN RENAL TRANSPLANT RECIPIENTS INFUSED WITH DONOR MARROW. I. POTENT REGULATORS OF RECIPIENT ANTIDONOR IMMUNE RESPONSES1 (2000) (51)
The definition of ABO factors in transplantation: relation to other humoral antibody states. (1987) (51)
Multivisceral transplantation for megacystis microcolon intestinal hypoperistalsis syndrome. (1999) (50)
Liver transplantation in older patients. (1987) (49)
Adenovirus enterocolitis in human small bowel transplants. (1998) (49)
Two-year experience with FK 506 in pediatric patients. (1993) (49)
Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis. (2001) (49)
Adrenal reserve in renal transplant recipients with cyclosporine, azathioprine, and prednisone immunosuppression. (1990) (49)
Liver transplantation using elderly donors: a risk factor analysis (2011) (48)
Sirolimus-Associated Hepatotoxicity in Liver Transplantation (2004) (48)
Successful living related liver transplantation in an adult with fulminant hepatic failure. (1997) (48)
Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. (1995) (47)
The human bone marrow as an immunoregulatory organ. (1999) (47)
Uterine transplantation--a real possibility? The Indianapolis consensus. (2013) (46)
Portosystemic shunting in children during the era of endoscopic therapy: improved postoperative growth parameters. (2000) (46)
Zoom endoscopic monitoring of small bowel allograft rejection (2006) (45)
Late mortality and morbidity after liver transplantation. (1987) (45)
OKT3 and viral disease in pediatric liver transplant recipients. (1991) (45)
The impact of Campath 1H induction in adult liver allotransplantation. (2005) (45)
The first case report of the use of a zoom videoendoscope for the evaluation of small bowel graft mucosa in a human after intestinal transplantation. (1999) (45)
Graft-versus-host disease after liver and small bowel transplantation in a child. (1997) (44)
Tregs Expanded In Vivo by TNFRSF25 Agonists Promote Cardiac Allograft Survival (2012) (44)
Organ Shortage: The Greatest Challenge Facing Transplant Medicine (2014) (44)
Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center. (2006) (44)
Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma. (1991) (44)
Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era. (2010) (43)
Clinical features of nosocomial rotavirus infection in pediatric liver transplant recipients. (1995) (43)
Disease gravity and urgency of need as guidelines for liver allocation (1994) (43)
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. (1991) (43)
The question of FK 506 nephrotoxicity after liver transplantation. (1991) (43)
Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency. (2003) (43)
Experience with primary liver transplantation across ABO blood groups. (1987) (42)
Effect of Liver Transplantation on Spleen Size, Collateral Veins, and Platelet Counts (2010) (42)
Monitoring and treatment of intestinal allograft rejection in humans. (1993) (42)
Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation. (2003) (42)
Impact of Orthoclone OKT3 on liver transplantation. (1987) (42)
Modulatory effects of human donor bone marrow cells on allogeneic cellular immune responses. (1997) (42)
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. (1991) (41)
Refractory Ascites After Liver Transplantation: An Analysis of 1058 Liver Transplant Patients at a Single Center (2006) (41)
Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study. (2005) (41)
Ethics of uterus transplantation with live donors. (2014) (41)
Outcome of liver transplantation using donors 60 to 79 years of age. (1995) (40)
Heme oxygenase-1 upregulation protects against intestinal ischemia/reperfusion injury: a laboratory based study. (2007) (40)
Replacement of donor lymphoid tissue in human small bowel transplants under FK 506 immunosuppression (1991) (40)
The role of intestinal transplantation in the management of babies with extensive gut resections. (2003) (40)
Utilization of Dried Blood Spot Citrulline Level as a Noninvasive Method for Monitoring Graft Function Following Intestinal Transplantation (2005) (40)
Use of OKT3 with Ciclosporin and Steroids for Reversal of Acute Kidney and Liver Allograft Rejection (1987) (39)
Mycobacterium abscessus infection in solid organ transplant recipients: report of three cases and review of the literature (2009) (39)
Liver transplantation in patients with situs inversus. (1990) (39)
Portal versus systemic drainage of small bowel allografts: comparative assessment of survival, function, rejection, and bacterial translocation. (2002) (39)
A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. (1994) (38)
Thrombocytopenia after liver transplantation. (1999) (38)
The effect of prednisone on pancreatic islet autografts in dogs. (1993) (38)
Nutritional management of intestinal transplant recipients. (1993) (38)
En bloc heterotopic auxiliary liver and bilateral renal transplant in a patient with homozygous protein C deficiency. (2001) (38)
Fecal Calprotectin Level Measurements in Small Bowel Allograft Monitoring: A Pilot Study (2008) (38)
Intestinal transplantation for the treatment of neoplastic disease (2005) (38)
MicroRNA Signature of Intestinal Acute Cellular Rejection in Formalin‐Fixed Paraffin‐Embedded Mucosal Biopsies (2012) (38)
A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection (2003) (38)
Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin (2009) (38)
Bacterial infections after intestine and multivisceral transplantation. The experience of the University of Miami (1994-2001). (2006) (38)
Predisposing Factors of Diminished Survival in Simultaneous Liver/Kidney Transplantation (2012) (38)
Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Outcome After Liver Transplantation (2010) (38)
Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction. (1998) (38)
Allogeneic uterus transplantation in baboons: surgical technique and challenges to long-term graft survival. (2014) (38)
Basiliximab in pediatric liver transplantation: A pharmacokinetic‐derived dosing algorithm (2002) (37)
Long-term (> 3-year) insulin independence in a patient with pancreatic islet cell transplantation following upper abdominal exenteration and liver replacement for fibrolamellar hepatocellular carcinoma. (1995) (37)
Citrulline Level Is a Potent Indicator of Acute Rejection in the Long Term Following Pediatric Intestinal/Multivisceral Transplantation (2012) (37)
Uterine transplantation research: laboratory protocols for clinical application. (2012) (36)
Long-term in vivo function of human mantled islets obtained by incomplete pancreatic dissociation and purification. (1995) (36)
Early tolerance in pediatric liver allograft recipients. (1994) (36)
Current status of small bowel transplantation in children: update 2003. (2003) (36)
Unusual presentation of graft‐versus‐host disease in pediatric liver transplant recipients: Evidence of late and recurrent disease (1999) (36)
Pediatric renal transplantation under FK-506 immunosuppression. (1991) (36)
Gastroduodenal artery steal syndrome during liver transplantation: intraoperative diagnosis with Doppler ultrasound and management (2005) (36)
Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse). (1992) (35)
Intestinal transplantation at the University of Miami-five years of experience. (2000) (35)
Treatment of upper abdominal malignancies with organ cluster procedures. (1990) (35)
Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients (2002) (35)
Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers (2003) (35)
FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood (1990) (35)
Eculizumab Salvage Therapy for Antibody‐Mediated Rejection in a Desensitization‐Resistant Intestinal Re‐Transplant Patient (2015) (35)
Acute pancreatitis after liver transplantation: incidence and contributing factors (1995) (35)
Multivisceral transplantation for pediatric intestinal pseudo-obstruction: single center's experience of 16 cases. (2004) (34)
Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesentery. (2003) (34)
Competing Risks Analysis of Predictors of Delisting Owing to Tumor Progression in Liver Transplant Candidates with Hepatocellular Carcinoma (2004) (34)
Use of FK 506 in pediatric patients. (1991) (34)
Multivisceral Ex Vivo Surgery for Tumors Involving Celiac and Superior Mesenteric Arteries (2012) (34)
Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients. (2002) (34)
Accidental transplantation of malignant tumor from a donor to multiple recipients. (1987) (34)
Clinical-Scale Isolation of Interleukin-2-Stimulated Liver Natural Killer Cells for Treatment of Liver Transplantation with Hepatocellular Carcinoma (2012) (34)
Lamivudine monoprophylaxis for liver transplant recipients with non‐replicating hepatitis B virus infection (2007) (34)
Multiple Bone Marrow Infusions to Enhance Acceptance of Allografts from the Same Donor (1995) (34)
FK 506 versus cyclosporine in pediatric liver transplantation. (1991) (34)
Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers. (1989) (34)
Human islet allografts in patients with type 2 diabetes undergoing liver transplantation. (1997) (34)
Intestinal transplantation for short gut syndrome attributable to necrotizing enterocolitis. (2000) (34)
Postoperative surgical complications. (1988) (33)
Transmission of fatal herpes simplex infection through renal transplantation. (1988) (33)
International grading scheme for acute cellular rejection in small-bowel transplantation: single-center experience. (2010) (33)
Liver transplantation for hepatocellular carcinoma (2004) (32)
Prevention of catheter‐related bacteremia in pediatric intestinal transplantation/short gut syndrome children with long‐term central venous catheters (2007) (32)
The Immune Reactivity Role of HCV-Induced Liver Infiltrating Lymphocytes in Hepatocellular Damage (1997) (32)
Equitable allocation of extrarenal organs: with special reference to the liver. (1988) (32)
Obstructing mucocele of the cystic duct after transplantation of the liver. (1989) (32)
Intestinal transplantation in children under FK 506 immunosuppression. (1993) (31)
Piggyback orthotopic intestinal transplantation. (1993) (31)
Use of a bioengineered skin equivalent for the management of difficult skin defects after pediatric multivisceral transplantation. (2005) (31)
Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization. (2006) (31)
Cytomegalovirus Prevalence and Transmission After Islet Allograft Transplant in Patients with Type 1 Diabetes Mellitus (2004) (31)
PRELIMINARY EXPERIENCE WITH FK506 IN THORACIC TRANSPLANTATION (1991) (31)
Trends in serum citrulline and acute rejection among recipients of small bowel transplants. (2004) (31)
Arterial mycotic aneurysm and rupture. A potentially fatal complication of pancreas transplantation in diabetes mellitus. (1989) (30)
Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. (1992) (30)
Body surface area index predicts outcome in orthotopic liver transplantation (2011) (30)
Liver transplantation for arteriohepatic dysplasia (Alagille's syndrome) (1992) (30)
Personal experience with the procurement of 132 liver allografts (1989) (30)
Intestinal and multivisceral autotransplantation for tumors of the root of the mesentery: Long-term follow-up. (2012) (30)
Abdominal wall transplantation: surgical and immunologic aspects. (2009) (30)
New immunosuppressive regimens in clinical intestinal transplantation. (1997) (29)
The liver transplant waiting list--a single-center analysis. (1991) (29)
Subclinical Rejection in the Initial Postoperative Period in Small Intestinal Transplantation: A Negative Influence on Graft Survival (2007) (29)
Liver transplant with portocaval hemitransposition: experience at the University of Miami. (2001) (29)
The effect of immunosuppression on peritoneal adhesions formation after small bowel transplantation in rats. (2007) (29)
Renal artery reconstruction for harvesting injuries in kidney transplantation with particular reference to the use of vascular allografts (1988) (29)
Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation (1994) (29)
Induction therapy for clinical intestinal transplantation: comparison of four different regimens. (2000) (29)
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication. (1991) (29)
Human Liver Cells Expressing Albumin and Mesenchymal Characteristics Give Rise to Insulin-Producing Cells (2011) (29)
Simvastatin‐Ezetimibe‐Induced Hepatic Failure Necessitating Liver Transplantation (2008) (28)
Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa‐2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing (2004) (28)
The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody. (1998) (28)
Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. (1991) (28)
Biliary tract complications in orthotopic adult liver transplantation. (1989) (28)
Citrulline evaluation in bowel transplantation. (2010) (28)
Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis (2004) (28)
Liver transplantation for severe hepatic trauma: experience from a single center. (2009) (28)
Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant. (1991) (28)
Liver Retransplantation of More Than Two Grafts for Recurrent Failure (2009) (28)
Long‐term deleterious effects of aortohepatic conduits in primary liver transplantation: Proceed with caution (2013) (28)
Mycophenolate mofetil rescue therapy in liver transplant recipients. (1997) (27)
Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism. (1997) (27)
Graft survival in pediatric liver transplantation. (2001) (27)
Diagnosis and treatment of cryptosporidium infection in intestinal transplant recipients. (2002) (27)
A Cause-Specific Hazard Rate Analysis of Prognostic Factors Among 877 Adults Who Received Primary Orthotopic Liver Transplantation (2007) (27)
Infectious complications of pediatric liver transplantation under FK 506. (1991) (27)
Propylthiouracil-Induced Acute Liver Failure: Role of Liver Transplantation (2010) (27)
Partial abdominal exenteration, ex vivo resection of a large mesenteric fibroma, and successful orthotopic intestinal autotransplantation. (2000) (27)
Improved rejection surveillance in intestinal transplant recipients with frequent use of zoom video endoscopy. (2000) (27)
Liver transplantation for tyrosinemia (2005) (27)
An Unusual Complication of Choledochocholedochostomy in Orthotopic Liver Transplantation (1988) (27)
Orthotopic liver transplantation for hemochromatosis. (1991) (27)
Domino liver transplantation with end-to-side infrahepatic vena cavocavostomy. (2001) (27)
Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation. (2004) (27)
Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans. (1991) (27)
Current status of FK 506 in liver transplantation. (1991) (27)
Acquired hepatocerebral degeneration in a patient with HCV cirrhosis: Complete resolution with subsequent recurrence after liver transplantation (2006) (27)
Liver transplantation under cyclosporine: a decade of experience. (1991) (27)
An association of lower serum citrulline levels within 30 days of acute rejection in patients following small intestine transplantation. (2006) (26)
Sirolimus (rapamycin)-based rescue treatment following chronic rejection after liver transplantation. (2001) (26)
Intestinal transplantation for short bowel syndrome secondary to gastroschisis. (2006) (26)
INVOLVEMENT OF MULTIPLE SUBPOPULATIONS OF HUMAN BONE MARROW CELLS IN THE REGULATION OF ALLOGENEIC CELLULAR IMMUNE RESPONSES1 (2000) (26)
Arterioportal fistula following liver biopsy. Three cases occurring in liver transplant recipients. (1995) (26)
Nonobstructing colonic dilatation and colon perforations following renal transplantation. (1990) (26)
Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation. (1988) (26)
FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome. (1991) (26)
Microbiologic surveillance as part of human islet transplantation: results of the first 26 patients. (1992) (26)
Viral interleukin-10-engineered autologous hematopoietic stem cell therapy: a novel gene therapy approach to prevent graft rejection. (2004) (25)
Strategy of FK 506 therapy in liver transplant patients: effect of graft function. (1991) (25)
Isolation and expansion of human natural T regulatory cells for cellular therapy. (2010) (25)
Donor infection and primary nonfunction in liver transplantation. (1997) (25)
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. (1994) (25)
Consumption of dietary supplements in a liver transplant population (2004) (25)
Framing the diagnosis and treatment of absolute uterine factor infertility: Insights from in-depth interviews with uterus transplant trial participants (2019) (25)
Concurrent Infantile Hemangioendothelioma and Mesenchymal Hamartoma in a Developmentally Arrested Liver of an Infant Requiring Hepatic Transplantation (2003) (25)
Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation (2009) (25)
Infectious complications after human small bowel transplantation. (1992) (25)
Liver transplantation for alcoholic liver disease: a consideration of reasons for and against. (1989) (25)
Intestinal transplantation at the University of Miami. (2002) (25)
Liver transplantation with preservation of the inferior vena cava: lessons learned through 2,000 cases. (2012) (25)
Small bowel transplantation--a clinical review. (1999) (25)
Detection of pancreatic islet tissue following islet allotransplantation in man. (1991) (24)
Mycophenolate mofetil as primary and rescue therapy in intestinal transplantation. (1998) (24)
Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome. (1995) (24)
Expanded liver donor age over 60 years for hepatic transplantation. (1997) (24)
Successful treatment with bortezomib of a refractory humoral rejection of the intestine after multivisceral transplantation. (2009) (24)
Orthotopic liver transplantation for massive hepatic lymphangiomatosis. (1988) (24)
Clinical small bowel or small bowel plus liver transplantation under FK 506. (1991) (24)
Uterine Transplantation: Surgical Innovation in the Treatment of Uterine Factor Infertility. (2018) (23)
Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation. (1998) (23)
Campath-1H in intestinal and multivisceral transplantation: preliminary data. (2002) (23)
Guidelines for standardized nomenclature and reporting in uterus transplantation: An opinion from the United States Uterus Transplant Consortium (2020) (23)
Overview of FK506 in transplantation. (1990) (23)
Tacrolimus-related microangiopathy in kidney and simultaneous pancreas-kidney recipients: evidence of endothelin and cytokine involvement. (1998) (23)
Infectious complications after small bowel transplantation in adults. (1994) (23)
Neurodevelopmental outcomes of infant multivisceral transplant recipients: a longitudinal study. (2006) (23)
Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation. (1991) (23)
Small bowel transplantation: technical advances/updates (2009) (23)
Effect of FK 506 on function of human islets of Langerhans. (1991) (23)
Smooth muscle tumor arising de novo in a liver allograft: A case report. (1991) (23)
Alloimmunization to Red Cell Antigens in Liver and Multivisceral Transplant Patients (2007) (22)
Immediate antibody-mediated (hyperacute) rejection in small-bowel transplantation and relationship to cross-match status and donor-specific C4d-binding antibodies: case report. (2010) (22)
Induction therapy with daclizumab as part of the immunosuppressive regimen in human small bowel and multiorgan transplants. (2001) (22)
Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patients. (2006) (22)
Small bowel transplantation—a clinical review (1999) (22)
Intestinal transplantation and bacterial overgrowth in humans. (1994) (22)
Uterus transplantation: organ procurement in a deceased donor model. (2018) (22)
Characteristic immune, apoptosis and inflammatory gene profiles associated with intestinal acute cellular rejection in formalin‐fixed paraffin‐embedded mucosal biopsies (2011) (22)
Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression. (2006) (21)
Intestinal transplantation in humans under FK 506. (1993) (21)
Routine use of auxiliary partial orthotopic liver transplantation for children with fulminant hepatic failure: Preliminary report. (2006) (21)
Acute cellular rejection grading scheme for human gastric allografts. (2004) (21)
Transplantation of islets of Langerhans in patients with insulin-requiring diabetes mellitus undergoing orthotopic liver transplantation – the Miami experience (1999) (21)
Uterus transplantation model in sheep with heterotopic whole graft and aorta and cava anastomoses. (2013) (21)
Liver transplantation for neonatal hepatitis as compared to the other two leading indications for liver transplantation in children. (1994) (21)
Renal function after pediatric intestinal transplant. (2006) (21)
Lymphoplasmacytic hyperplasia (possibly pre-PTLD) has varied expression and appearance in intestinal transplant recipients receiving Campath immunosuppression. (2004) (21)
The hepatic artery in orthotopic liver transplantation. (1988) (21)
Clinical considerations in orthotopic liver transplantation. (1987) (21)
Cerebral mucormycosis after liver transplantation: a case report. (1998) (21)
The presence of hepatitis B core antibody does not preclude kidney donation: lack of viral DNA in the serum and biopsies of core antibody-positive donors and clinical follow-up. (1997) (21)
Is the graft too big or too small? Technical variations to overcome size incongruity in visceral organ transplantation. (1998) (21)
Longterm outcomes of auxiliary partial orthotopic liver transplantation in preadolescent children with fulminant hepatic failure (2016) (20)
Does transjugular intrahepatic portosystemic shunting facilitate or complicate liver transplantation? (1997) (20)
Preliminary experience with FK 506 in thoracic transplantation (1991) (20)
Clinical intestinal transplantation. (1996) (20)
Clinical intestinal transplantation: focus on complications. (1992) (20)
Growth after intestinal transplant in children. (2006) (20)
Clinical outcome of intestinal transplantation at the University of Miami. (1999) (20)
Small bowel and liver/small bowel transplantation in children. (1993) (20)
Immunodepletion in xenotransplantation. (1990) (20)
FK506 in pediatric kidney transplantation—Primary and rescue experience (2004) (20)
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. (1992) (20)
Partial Bladder Transplantation with En Bloc Kidney Transplant—The First Case Report of a ‘Bladder Patch Technique’ in a Human (2008) (20)
Role of endoscopy following small intestinal transplantation in children. (1994) (20)
The transplantation of gastrointestinal organs. (1993) (20)
Analysis of Vascular Access in Intestinal Transplant Recipients Using the Miami Classification from the VIIIth International Small Bowel Transplant Symposium (2005) (20)
Surgical techniques used in intestinal transplantation (2004) (20)
Herpes simplex colitis in a child with combined liver and small bowel transplant (2001) (19)
Evolution of surgical techniques in clinical intestinal transplantation. (1994) (19)
Cytomegalovirus prophylaxis with ganciclovir and cytomegalovirus immune globulin in liver and intestinal transplantation (2001) (19)
Burkitt’s lymphoma variant of post-transplant lymphoproliferative disease (PTLD) (2009) (19)
Upper-abdominal exenteration in transplantation for extensive malignancies of the upper abdomen--an update. (1991) (19)
Small bowel transplantation: current progress and clinical application. (1996) (19)
Liver transplant for the septuagenarians: importance of patient selection. (2004) (19)
Use of hepatitis C-infected donors for hepatitis C-positive OLT recipients. (1999) (19)
Levels of mycophenolic acid and its glucuronide derivative in the plasma of liver, small bowel and kidney transplant patients receiving tacrolimus and cellcept combination therapy. (2000) (19)
Polyomavirus PCR monitoring in renal transplant recipients: detection in blood is associated with higher creatinine values. (2001) (19)
Liver transplantation in black recipients: Pittsburgh. (1989) (19)
Alveolar Echinococcosis induced liver failure: salvage by liver transplantation in an otherwise uniformly fatal disease (2008) (19)
Multivisceral and intestinal transplantation. (1992) (19)
Uterus transplantation: state of the art in 2021 (2021) (18)
Early infectious complications of liver-intestinal transplantation in children: preliminary analysis. (1994) (18)
Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. (1991) (18)
Intestinal transplantation at the University of Pittsburgh. (1994) (18)
Characterizing women with interest in uterine transplant clinical trials in the United States: who seeks information on this experimental treatment? (2017) (18)
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. (1995) (18)
OKT3 in the reversal of acute hepatic allograft rejection. (1987) (18)
Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression. (1998) (18)
Use of a Living Dermal Equivalent for a Refractory Abdominal Defect after Pediatric Multivisceral Transplantation (2004) (18)
Mycophenolate mofetil-related gastrointestinal mucosal injury in multivisceral transplantation. (2010) (18)
Uterine viability in the baboon after ligation of uterine vasculature: a pilot study to assess alternative perfusion and venous return for uterine transplantation. (2017) (18)
Acquired hyperplastic gastric polyps in solid organ transplant patients (2002) (18)
Reversal of Graft-Versus-Host Disease with Infusion of Autologous Bone Marrow (1994) (18)
Pediatric liver transplantation from neonatal donors (1992) (17)
Liver transplantation for hepatopulmonary syndrome due to noncirrhotic portal hypertension. (2011) (17)
Upper abdominal exenteration with liver replacement: a modification of the "cluster" procedure. (1990) (17)
Neuodevelopmental outcomes for children transplanted under the age of 3 years. (2006) (17)
Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients. (2012) (17)
Liver Transplantation for the Budd‐Chiari Syndrome (1976) (17)
Isolated mandibular metastasis of hepatocellular carcinoma. (1992) (17)
A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation. (2012) (17)
Endorectal pull-through of transplanted colon as part of intestinal transplantation. (1995) (17)
Atheroembolic involvement of renal allografts. (1989) (17)
Analysis of Acute and Chronic Rejection in Multiple Organ Allografts From Retransplantation and Autopsy Cases of Multivisceral Transplantation (2008) (17)
Is multiple organ failure a contraindication for liver transplantation in children? (1987) (17)
Liver retransplantation in adults: overall results and determinant factors affecting the outcome. (1991) (17)
Liver transplantation for factor VII deficiency. (2001) (17)
Exfoliative bowel rejection – a dangerous loss of integrity (2004) (17)
'Domino' liver transplantation combined with multivisceral transplantation. (1997) (17)
Endoscopy is essential for early detection of rejection in small bowel transplant recipients. (1994) (16)
Are liver grafts from hepatitis B surface antigen negative/anti-hepatitis B core antibody positive donors suitable for transplantation? (2001) (16)
Intestinal and multivisceral transplantation after abdominal trauma. (2004) (16)
Experience with intestinal transplantation at the University of Miami. (1996) (16)
Bile leakage following T-tube removal in orthotopic liver transplantation. (1999) (16)
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. (1992) (16)
DONOR AND RECIPIENT PRETRANSPLANT CONDITIONING WITH NONLETHAL RADIATION AND ANTILYMPHOCYTE SERUM IMPROVES THE GRAFT SURVIVAL IN A RAT SMALL BOWEL TRANSPLANT MODEL1,2 (2001) (16)
The role of liver transplantation in the subacute trauma patients. (1998) (16)
Management of portal vein thrombosis in liver transplantation. (1997) (16)
Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis. (1994) (16)
Intestinal transplantation: 4-year experience. (1995) (16)
Biliary complications in liver allografts after hepatic artery occlusion: A 6-year study (1988) (16)
The Importance of Analyzing Graft and Patient Survival by Cause of Failure: An Example Using Pediatric Small Intestine Transplant Data (2006) (16)
Temporary end-to-side portocaval shunt in orthotopic liver transplantation (1993) (16)
Liver transplantation for HIV-infected patients with end-stage liver disease (2002) (15)
Gastrointestinal tract ulcers in pediatric intestinal transplantation patients: Etiology and management (2006) (15)
Portal vein arterialization using an accessory right hepatic artery in liver transplantation (2013) (15)
FK 506 in small bowel transplant recipients: pharmacokinetics and dosing. (1994) (15)
Recurrence of desmoid tumor in a multivisceral transplant patient with Gardner's syndrome. (1999) (15)
Toward the biologic release of human insulin from skeletal muscle. (1997) (15)
In vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation. (1999) (15)
Clinical intestinal transplantation: experience in Miami. (1997) (15)
The anterior route for arterial graft conduits in liver transplantation * (1989) (15)
Analysis of post-transplant immune status in recipients of liver/bone marrow allografts. (1999) (15)
Renal transplantation in black recipients at the University of Pittsburgh. (1989) (14)
Cambridge-Miami score for intestinal transplantation preoperative risk assessment: initial development and validation. (2010) (14)
Liver natural killer cell inoculum for liver transplantation with hepatocellular carcinoma (2013) (14)
Cloning and expression of canine interleukin-10. (1995) (14)
Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism. (1995) (14)
Bone marrow cells inhibit the generation of autologous EBV-specific CTL. (2000) (14)
Is severe rejection an indication for retransplantation? (2000) (14)
Human islet isolation and purification from pediatric-age donors. (1991) (14)
Erratum: The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation (Transplantation (November 27, 1999) 68:10 (1532-1541)) (2000) (14)
Arterioportal fistula following liver biopsy (1995) (14)
Twelve years' experience with non-heart-beating cadaveric donors. (1996) (14)
Human islet allotransplantation under FK 506. (1991) (14)
Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts. (1996) (14)
Liver transplantation for primary biliary cirrhosis. (1989) (14)
Significance of blood flow measurement in clinical liver transplantation. (1989) (14)
In situ enzymatic oligonucleotide amplification of hepatitis C virus-RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver disease. (1998) (14)
Donor peripheral blood stem cell infusions in recipients of living-related liver allografts. (1997) (14)
Human liver xenotransplantation. (1993) (14)
Composition of human islet cell preparations for transplantation (2004) (14)
Liver transplantation at the University of Pittsburgh, 1984 to 1990. (1991) (14)
Mucosal fibrosis in intestinal transplant biopsies correlates positively with the development of chronic rejection. (2006) (13)
Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up. (1997) (13)
Status of liver and gastrointestinal transplantation at the University of Miami. (1996) (13)
Chronic kidney disease after orthotopic liver transplantation in recipients receiving tacrolimus. (2011) (13)
Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases. (1992) (13)
Sclerosing mesenteritis in small bowel transplantation: possible manifestation of acute vascular rejection. (2003) (13)
Gene expression profiling of MicroRNAs in small-bowel transplantation paraffin-embedded mucosal biopsy tissue. (2010) (13)
Factors affecting metabolic and electrolyte changes after reperfusion in liver transplantation. (2004) (13)
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. (1993) (13)
Pediatric kidney transplantation at the University of Pittsburgh. (1994) (13)
Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation. (1998) (13)
Use of microwave coagulation therapy in liver transplant candidates with hepatocellular carcinoma: a preliminary report. (2001) (13)
Two year experience with FK506 in pediatric patients (1993) (13)
Donor selection and surgical technique for en bloc liver-small bowel graft procurement. (1993) (13)
Donor biliary variations: an overlooked problem? (1997) (13)
Devastating intracardiac and aortic thrombosis: a case report of apparent catastrophic antiphospholipid syndrome during liver transplantation. (2011) (13)
International grading scheme for acute rejection in small bowel transplantation: implementation and experience at the University of Miami. (2006) (13)
Role of liver transplantation in the management of liver trauma. (1997) (12)
T cell lymphoma involving the graft of a multivisceral organ recipient. (1999) (12)
A new technique of extravesical ureteroneocystostomy for renal transplantation. (1989) (12)
Rejection of human intestinal allografts: alone or in combination with the liver. (1994) (12)
Neurodevelopmental outcomes of infant intestinal transplant recipients. (2004) (12)
Host-derived enterocytes in intestinal grafts. (2002) (12)
Segmental xanthomatosis of the small intestine. A case report and review of the literature. (2009) (12)
Correlation between allograft survival and chimeric state after bone marrow infusion in rat small bowel transplantation (1999) (12)
Pediatric liver transplant with Campath 1H induction--Preliminary report. (2006) (12)
Viral interleukin-10 gene therapy to induce tolerance to solid organ transplants in mice. (2004) (12)
Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation. (1997) (12)
Transplantation for the Treatment of Intra-Abdominal Fibromatosis (2005) (12)
Combined bone marrow and whole organ transplantation from the same donor. (1994) (12)
CD55 and CD59 deficiency in transplant patient populations: possible association with paroxysmal nocturnal hemoglobinuria-like symptoms in Campath-treated patients. (2006) (12)
Xenotransplantation of hematopoietic cells resistant to HIV as a potential treatment for patients with AIDS. (1994) (12)
Effect of pretransplant hepatitis C virus RNA status on posttransplant outcome. (2008) (12)
Nonhuman primates as models for transplantation of the uterus. (2013) (12)
Human islet allotransplantation in 18 diabetic patients. (1992) (11)
Assessment of an Alternative to the Uterine Vein for Venous Drainage in Human Uterine Transplantation: A Case Series Following Laparoscopic Hysterectomy (2016) (11)
Sorafenib in hepatocellular carcinoma (HCC) patients after liver transplantation. (2009) (11)
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. (1987) (11)
The Miami experience with almost 100 multivisceral transplants. (2006) (11)
Effect of donor age and sex on the outcome of liver transplantation (1995) (11)
Surgical considerations in liver transplantation: small for size syndrome. (2009) (11)
FK 506 in simultaneous pancreas/kidney transplantation: the University of Miami experience. (1997) (11)
Use of the D-xylose absorption test in monitoring intestinal allografts. (1994) (11)
Noncomposite simultaneous liver and intestinal transplantation. (2004) (11)
Intestinal transplantation: advances in immunosuppression and surgical techniques. (2003) (11)
Intestinal and multivisceral transplantation: future perspectives. (2007) (11)
Evolution of gastrointestinal transplantation at the University of Miami. (2001) (11)
Association between panel reactive antibodies and acute small bowel rejection: analysis of a series of 324 intestinal transplants. (2010) (11)
Hyperacute rejection of the kidney in patients with a negative crossmatch. (1988) (11)
Necrotizing fasciitis following liver and small intestine transplantation (2002) (11)
Cadaveric small bowel/split liver transplantation in a child (1999) (11)
Meeting Report: Second World Congress of the International Society of Uterus Transplantation, Cleveland (2020) (10)
Etiology and management of alimentary tract ulcers in pediatric intestinal transplantation patients. (2006) (10)
Islet transplantation in type II diabetes. (1995) (10)
Mass Clamping of the Hilum to Facilitate Difficult Hepatectomy During Liver Transplantation: A Single Center 10 Year Experience (2009) (10)
Use of donor aorta for arterial reconstruction in paediatric liver and multivisceral transplantation (2004) (10)
Livebirth and utero-placental insufficiency in Papio hamadryas baboons with uterus angiosome perfused by bilateral utero-ovarian microsurgical anastomoses alone (2017) (10)
Contrast examination of the small bowel in patients with small-bowel transplants: findings in 16 patients. (1993) (10)
Partial dearterialization of the liver allograft (1990) (10)
Intrapancreatic islet transplantation as a potential solution to chronic failure of intraportal islet grafts. (1993) (10)
Control of post-transplant lymphoproliferative disorders and Kaposi's sarcoma by modulation of immunosuppression (1987) (10)
Preservation of livers with UW or Euro-Collins' solution. (1988) (10)
Apoptosis and rejection in rat intestinal transplantation: correlation with FK506 doses and donor specific bone marrow infusions. (2001) (10)
Pediatric Liver Transplantation (1993) (10)
Peripheral Blood Gene Expression Analysis in Intestinal Transplantation: A Feasibility Study for Detecting Novel Candidate Biomarkers of Graft Rejection (2011) (10)
FK 506 in clinical organ transplantation (1991) (10)
Expression of MUC2 and MUC4 proteins and cytokines: early markers of intestinal graft rejection1,2 (2003) (10)
Detection of intrahepatic human islets following combined liver-islet allotransplantation. (1992) (10)
Hepatic artery thrombosis following pediatric liver transplantation: Assessment of blood flow measurement in allografts. (1989) (10)
The use of FK 506 in new-onset type I diabetes in man. (1991) (10)
Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras. (1992) (10)
Early graft loss secondary to massive hemorrhagic necrosis following orthotopic liver transplantation. Evidence for cytokine-mediated univisceral Shwartzman reaction. (1996) (10)
Expanded use of multivisceral transplantation for small children with concurrent liver and intestinal failure. (2006) (10)
Technical aspects of intestinal transplantation. (1993) (10)
Multivisceral transplantation without the liver. (2002) (10)
Case of pediatric acquired chronic hepatocerebral degeneration. (2008) (10)
Temporal relationships between acute cellular rejection features and increased mucosal fibrosis in the early posttransplant period of human small intestinal allografts. (2002) (10)
Factor V Leiden mutation is a risk factor for hepatic artery thrombosis in liver transplantation. (2013) (10)
Role of Innate and Acquired Immune Mechanisms in Clinical Intestinal Transplant Rejection (2015) (10)
Infections in pediatric liver recipients treated for acute rejection. (1989) (9)
Pancreas procurement from multiorgan donors for islet trasplantation. (1992) (9)
Induction of Auto-reactive Regulatory T Cells by Stimulation with Immature Autologous Dendritic Cells (2007) (9)
Rituximab treatment for posttransplantation lymphoproliferative disorder after small bowel transplantation. (2002) (9)
Routine use of the piggyback technique in pediatric orthotopic liver transplantation. (1996) (9)
Organ-specific differences in acute rejection intensity in a multivisceral transplant. (2006) (9)
Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. (1992) (9)
Rubella infection after orthotopic liver transplantation. (1994) (9)
Initial studies with FK506 in renal transplantation. (1991) (9)
Pilot study to determine the safety and feasibility of deceased donor liver natural killer cell infusion to liver transplant recipients with hepatocellular carcinoma (2021) (9)
Primary Vibrio vulnificus bacteremia in a liver transplant recipient after ingestion of raw oysters: caveat emptor. (1999) (9)
Effect of the immunosuppressant FK 506 on insulin release from adult rat islets of Langerhans. (1991) (9)
Functional and phenotypic properties of peripheral T cells anergized by autologous CD3(+) depleted bone marrow cells. (2002) (9)
Epithelial and hematopoietic cell chimerism in intestinal allografts. (2004) (9)
Split liver transplantation. (2011) (9)
Use of the recipient celiac trunk for hepatic artery reconstruction in orthotopic liver transplantation. (2013) (9)
Comparative analysis of T-cell depletion method for clinical immunotherapy-anti-hepatitis c effects of natural killer cells via interferon-γ production. (2013) (8)
Cyclosporine immunosuppression and delayed graft function in 455 cadaveric renal transplants. (1987) (8)
Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy. (1996) (8)
Liver and small bowel transplantation for short gut syndrome in a child (1991) (8)
Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice. (1991) (8)
The Denver-Pittsburgh liver transplant series. (1987) (8)
Intraoperative donor cholangiography. (1998) (8)
Inclusion of spleen in pediatric multivisceral transplantation. (2006) (8)
Anatomy of the Internal Iliac Vein: Implications for Uterine Transplant. (2016) (8)
Use of percutaneous liver biopsies in marginal liver donors. (2001) (8)
Preoperative Embolization of the Graft Superior Mesenteric Artery Assists Graft Enterectomy in Intestinal Transplant Recipients (2012) (8)
Mucosal vascular alterations in the early posttransplant period of small bowel allograft recipients may reflect humoral-based allograft rejection. (2002) (8)
Intestinal transplantation with or without other abdominal organs: nutritional and dietary management of 50 patients. (1994) (8)
Developing strategies for prevention and treatment of recurrent HBV in liver transplantation. (1999) (8)
Portosystemic shunt for the treatment of portal vein thrombosis following orthotopic liver transplantation (1994) (8)
Treatment of recurrent hepatitis C after liver transplantation with IL-2r Ab. (2001) (8)
The impact of donor chemical overdose on the outcome of liver transplantation (2003) (8)
Preservation injury patterns in liver transplantation associated with poor prognosis. (2003) (8)
Morphological monitoring of human small bowel allografts. (1993) (8)
Higher percentage of donor CD 34+ expression in peripheral blood of simultaneous pancreas/kidney/donor bone marrow versus than kidney/islet cell/donor bone marrow recipients. (1998) (8)
Donor bone marrow infusions are tolerogenic in human renal transplantation. (2001) (8)
Evolving Ethical Issues with Advances in Uterus Transplantation. (2020) (8)
Pancreatic complications following orthotopic liver transplantation. (1992) (8)
The anterior route for arterial graft conduits in liver transplantation (1989) (8)
The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation. (2006) (8)
The impact of donor cocaine use on the outcome of adult liver transplantation (2006) (8)
Effect of timing of donor bone marrow infusions on liver allograft survival. (1997) (8)
TRANSPLANTATION FOR THE TREATMENT OF INTRA ABDOMINAL FIBROMATOSIS. (2004) (8)
Kidney transplantation in Pittsburgh: experience and innovations. (1987) (8)
Liver transplantation in older patients (Letter) (1987) (7)
The First 5 Years of Uterus Transplant in the US: A Report From the United States Uterus Transplant Consortium. (2022) (7)
Insulin independence for 58 months following pancreatic islet cell transplantation in a patient undergoing upper abdominal exenteration. (1995) (7)
Non-tuberculous mycobacterial associated enterocolitis in intestinal transplantation. (1998) (7)
Infrahepatic Vena Cavocavostomy, a Modification of the Piggyback Technique for Liver Transplantation (2009) (7)
Abnormal gastric emptying after intestinal transplantation. (1994) (7)
Interferon alfa and ribavirin in established post liver transplant recurrent hepatitis C infection (1998) (7)
Evidence for microchimerism in peripheral blood, bone marrow, and skin following donor bone marrow/kidney-pancreas transplantation at 3 years. (1998) (7)
Factors associated with recurrent cytomegalovirus disease after small bowel transplantation. (1994) (7)
Liver-islet transplantation in type 2 diabetes. (1997) (7)
Preliminary treatment results of pegylated interferon alpha 2B and ribavirin in liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2B and ribavirin (2003) (7)
Impact of Steroids on Natural Killer Cells Against Cytotoxicity and Hepatitis C Virus Replication. (2017) (7)
Human islet isolation and transplantation in chronic pancreatitis using the automated method. (1992) (7)
TIMY--a center-oriented transplant information management system. (1988) (7)
Twelve Years' Experience with Non—Heart-Beating Cadaveric Donors (1996) (7)
Cavoatrial shunt in the treatment of suprahepatic vena cava stricture after liver transplantation (2004) (7)
Anastomotic Healing in a Small Bowel Transplantation Model in the Rat (2003) (7)
Visual improvement after long-term success of pancreatic transplantation. (1990) (7)
Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation. (2002) (7)
Improving results of pediatric renal transplantation. (1994) (7)
Backtable angioscopy to evaluate the renal artery. (1992) (7)
Association of engraftment and islet cell function in bone marrow infused diabetic solid organ recipients (1996) (7)
Pancreatico-duodenal transplantation with enteric exocrine drainage (1988) (7)
Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients1 (2002) (7)
Clinical and endoscopic features of rejection in small bowel transplant recipients. (1994) (7)
Analysis of rejection episodes in over 100 pediatric intestinal transplant recipients. (2006) (7)
Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection. (1999) (7)
Successful liver transplantation for isoniazid-induced hepatic failure--a case report. (1994) (7)
Assessment of the effects of cadaveric donor bone marrow on chimerism in kidney transplant recipients by the polymerase chain reaction-flow technique. (1997) (7)
Histologic monitoring of human small bowel allografts with clinical correlation. (1992) (6)
Intestinal and multiple organ transplantation (1995) (6)
Candidates for intestinal transplantation and possible indicators of outcome. (1994) (6)
A simplified technique for the treatment of simple pleural effusions. (1987) (6)
Systemic versus portal venous drainage of small bowel grafts: similar long-term outcome in spite of increased bacterial translocation. (2002) (6)
Human donor bone marrow cells induce in vitro "suppressor T cells" that functionally suppress autologous B cells. (2003) (6)
Eating difficulties in the pediatric small bowel recipient: the role of the nutritional management team. (1994) (6)
Small bowel transplantation in children. (1997) (6)
Mixed allogeneic chimerism by combined use of nonlethal radiation and antilymphocyte serum in a rat small bowel transplantation model. (2000) (6)
Induction therapy for adult small bowel transplant with Campath-1H. (2002) (6)
Combined liver and kidney transplantation with particular reference to positive cytotoxic crossmatches (1989) (6)
Atypical chronic myeloid leukemia following organ transplants (2007) (6)
Acquired hyperplastic gastric polyps in solid organ transplant patients. (2002) (6)
The first live birth subsequent to uterus transplantation. (2015) (6)
Vitiligo Improvement in a Hepatitis C Patient After Treatment With PEG-Interferon α-2A and Ribavirin: A Case Report (2007) (6)
Venous reconstruction of pediatric en-bloc kidneys for transplantation. (1990) (6)
Intestinal and multivisceral transplantation at the University of Miami. (2009) (6)
Human islet allograft follow-up: long-term islet function and over 3 years of insulin independence. (1994) (6)
Intestinal autotransplantation for the treatment of pathologic lesions at the root of the mesentery. (2002) (6)
Changes of portal venous flow velocity after liver transplantation and its causes. (1994) (6)
Donor bone marrow infusion in renal transplantation. (1998) (6)
Life underneath the VCA umbrella: Perspectives from the US Uterus Transplant Consortium (2020) (6)
Mannose binding lectin (mbl2) haplotype frequencies in solid organ transplant patients and correlation with MBL protein levels--evaluation of complement-mediated effector pathway deficiency. (2013) (6)
Budd–Chiari‐like presentation of hepatic adenoma (2005) (6)
Donor bone marrow, chimerism, histocompatibility and renal allograft rejection. (1999) (6)
Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension (1994) (6)
Contemporaneous chronic rejection of multiple allografts with principal pancreatic involvement in modified multivisceral transplantation (2007) (5)
Intestinal and multivisceral transplantation. (2004) (5)
CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment (2016) (5)
Small bowel and multivisceral transplantations (2005) (5)
Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. (1987) (5)
Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (F344 rat to B10 mouse). (1992) (5)
Right trisectionectomy of the liver for intrahepatic cholangiocarcinoma with bile duct invasion in a Jehovah's Witness. (2007) (5)
A novel micro-cell-mediated lympholytic assay for the evaluation of regulatory cells in human alloreactive CTL responses. (2003) (5)
Let's play dominos (2000) (5)
Quantitative in Situ Analysis of FoxP3+ T Regulatory Cells on Transplant Tissue Using Laser Scanning Cytometry (2012) (5)
Uterus Recovery from Deceased Donor: Simple Technique Securing Safety of Vital Organs and Uterus Graft. (2020) (5)
PCR-flow analysis used to detect the levels of chimerism in peripheral blood of bone-marrow infused organ allograft recipients at the time of rejection episodes. (1997) (5)
Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report. (1996) (5)
Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man. (1993) (5)
Study of the development and evolution of neointestine in a rat model. (2004) (5)
Living donor intestinal transplantation – Should it be used more frequently? (2006) (5)
Frequency of kidney rejection in diabetic patients undergoing simultaneous kidney and pancreatic islet cell transplantation. (1993) (5)
Uterus Transplantation: Medical Considerations (2016) (5)
Combined liver-islet allotransplantation in man under FK 506. (1991) (5)
Cellular composition of islet cell suspensions for transplantation. (1992) (5)
Preoperative Comorbidity Correlates Inversely with Survival after Intestinal and Multivisceral Transplantation in Adults (2013) (4)
Management of allograft-replaced right hepatic arteries in liver transplantation: a review of the University of Miami experience and a preferred method of reconstruction. (1997) (4)
Liver and gastrointestinal transplantation at the University of Miami. (2003) (4)
Immunoenzymatic and morphological detection of epithelial cell apoptotic stages in gastrointestinal allografts from multivisceral transplant patients. (2004) (4)
Allogeneic hematopoietic stem cell transplantation in recipients of cellular or solid organ allografts. (1999) (4)
Pediatric intestinal transplantation: Literature review 2006–2007 (2008) (4)
Pitfalls of domino transplant. (2002) (4)
Simultaneous antibody-mediated rejection of multiple allografts in modified multivisceral transplantation. (2006) (4)
Recurrent hepatitis C infection following orthotopic liver transplantation is predicted by posttransplant serum and hepatic allograft viral titers. (1997) (4)
Extra-anatomical Meso-portal Venous Jump Graft Repair for Early Portal Vein Thrombosis After Liver Transplant in an Infant With a Hypoplastic Portal Vein: A Case Report. (2016) (4)
PORTAL VEIN THROMBOEMBOLISM OF LIVER ALLOGRAFTS FROM SPLENECTOMIZED DONORS (1989) (4)
A new approach to portal vein reconstruction in liver transplantation in patients with distal splenorenal shunts. (2001) (4)
New Frontier: Role of the Radiologist in Uterine Transplantation. (2019) (4)
[Critical value of citrulline for complications of intestinal transplant graft]. (2008) (4)
Liver transplantation today. (1987) (4)
Cadaveric renal transplantation at the University of Pittsburgh: a two and one-half-year experience with the point system. (1988) (4)
Report from studies of pediatric liver transplantation (SPLIT). SPLIT Research Group. (1999) (4)
Early clinical and histologic viability of human liver-small intestinal allografts after implantation. (1994) (4)
Intestinal transplantation for trauma patients. (2002) (4)
Temporary elevation of serum transaminases after pediatric intestinal transplantation: incidence and clinical correlation in multivisceral transplant vs isolated intestinal transplant. (2006) (4)
Pulmonary embolism with bone fragments following vertebral body marrow infusion for tolerance induction. (1996) (4)
ABROGATION OF THE ALLOREACTIVE RESPONSES OF CADAVER DONOR INTESTINAL LYMPHOCYTES BY INTRA-OPERATIVE CAMPATH-1H EXPOSURE (2004) (3)
A Case Report of Severe Hepatic Artery Vasospasm Induced by Hepatic Arterial Buffer Response After Liver Transplantation. (2016) (3)
Outcome of exfoliative rejection after isolated intestinal transplantation in an adult: case report. (2010) (3)
On Gender and Reproductive Decision-Making in Uterine Transplantation (2018) (3)
Abrogation of the alloreactive responses of cadaveric donor intestinal lymphocytes by intraoperative Campath-1H exposure. (2004) (3)
Role of the liver and the portal circulation in intestinal grafting (1993) (3)
Percutaneous approach for human islet transplantation. (1992) (3)
Notes on FK 506. (1991) (3)
Antibody-Mediated Rejection of Human Orthotopic Liver Allografts A Study of Liver Transplantation Across ABO Blood (1988) (3)
Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts. (1993) (3)
Immunophenotyping and cellular immune responses of cadaveric donor bone marrow cells. (1998) (3)
Treatment with FK 506 of steroid resistent focal sclerosing glomerulonephritis (FSGN) of childhood (Letter) (1990) (3)
HBV and HCC: comment on "Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience". (2009) (3)
Renal Transplantation in the Presence of a Positive Cytotoxic Antibody. (1988) (3)
Perioperative donor bone marrow infusion in cadaver kidney transplant recipients. (2001) (3)
Liver transplantation without immunosuppression: future perspectives. (1996) (3)
Basic considerations for the procurement of intestinal grafts. (1994) (3)
Donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation as regulators of autologous immune responses. (2001) (3)
Early recognition of alpha-1 antitrypsin deficiency and considerations for liver transplantation. (2013) (3)
Transplantation of the small bowel and other abdominal organs in humans (1994) (3)
Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy (2019) (3)
New trends in multivisceral transplantation (2006) (3)
Outcome of human islet isolation and allotransplantation in 20 consecutive cases. (1992) (3)
Adoptive immunotherapy using liver natural killer cells for preventing recurrence of hepatocellular carcinoma in cadaveric donor liver transplantation (53.20) (2012) (3)
Multi-organ procurement and successful multi-center allocation using rapid en bloc technique from a controlled non-heart-beating donor. (2004) (3)
Semiquantitative measurement of mucosal fibrosis as a means of assessing chronic injury in bowel allografts. (2002) (3)
Graft failure in two multivisceral transplant recipients secondary to necrotizing enterocolitis. (2000) (3)
SELECTIVE DECONTAMINATION IN PEDIATRIC LIVER TRANSPLANTS (1993) (3)
Current status of diagnosis of small bowel rejection. (1998) (3)
Effect of preservation conditions on human vertebral body marrow. (1995) (3)
Valor crítico da citrulina para as complicações do enxerto no transplante de intestino (2008) (3)
Donor bone marrow infusions in conjunction with liver-islet allotransplantation in patients with type 2 diabetes. (1997) (3)
Pediatric Intensive Care Unit (PICU) Utilization and Outcome in a Solid Organ Transplant Population: 5 (2005) (2)
Gastroduodenal Artery as the Inflow Tract to Repair the Right Hepatic Artery in a Combined Vasculobiliary Injury after Laparoscopic Cholecystectomy (2007) (2)
Thrombocytopenia following liver transplantation (1998) (2)
STEROID-FREE INDUCTION AND PRE-EMPTIVE ANTIVIRAL THERAPY FOR LIVER TRANSPLANT RECIPIENTS WITH HEPATITIS C – A PROSPECTIVE RANDOMIZED STUDY (2004) (2)
INCREASED HEPATITIS C VIREMIA IN CHOLESTATIC HEPATITIS C FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION. IS THE PATHOGENECITY OF THE SYNDROME RELATED TO VIRAL CYTOPATHIC MECHANISMS (1998) (2)
In situ quantitative immunoprofiling of regulatory T cells using laser scanning cytometry. (2009) (2)
Relative resistance of activated T cells and NK cells to alemtuzumab (Campath-1H) used in clinical transplantation (2004) (2)
Breaking the Donor Age Barrier to Face the Organ Shortage in Liver Transplantion (1995) (2)
Use of 3-dimensional imaging reconstruction in the treatment of advanced intra-abdominal desmoid tumors. (2012) (2)
Assessment of homozygosity in HLA-class I antigens and their distribution/quantitation in subpopulations of T cells by flow cytometry. (1996) (2)
Future of living-related small bowel transplantation in children. (1998) (2)
INTESTINAL TRANSPLANTATION IN CHILDREN – A SINGLE CENTER EXPERIENCE OVER 100 CASES (2004) (2)
SAFETY OF TRANSRADIAL CARDIAC CATHETERIZATION IN PATIENTS WITH END-STAGE LIVER DISEASE (2011) (2)
53 – Transplantation of the Liver with Digestive Organs (2005) (2)
Prediction of survival outcome of ICU patients awaiting orthotopic liver transplantation. (2002) (2)
Hepatic xenotransplantation: Clinical experience (1994) (2)
Update in transplantation--1997. (1997) (2)
A simple and safe roll over sleeve technique for venous anastomosis. (1990) (2)
Histologic finding of pancreatic islet tissue following intraportal human islet allotransplantation. (1992) (2)
An isolated complete intestinal transplantation in an adult: A complicated postoperative course (1992) (2)
OKT 3 and viral disease in pediatric liver transplant recipients (2010) (2)
Immunoreactivity of T lymphocytes propagated from biopsies of human cadaveric small intestine allografts: a serial study of four patients. (1992) (2)
DISPOSITION OF BASILIXIMAB, AN IL-2 RECEPTOR (CD25) CHIMERIC MONOCLONAL ANTIBODY, IN PEDIATRIC LIVER TRANSPLANT PATIENTS (1999) (2)
Metastatic squamous cell carcinoma to the liver presenting as hepatic cysts. (2011) (2)
DONOR BONE MARROW, CHIMERISM, HISTOCOMPATIBILITY AND RENAL ALLOGRAFT REJECTION (1998) (2)
Randomized prospective study of the comparative efficacy of spectinomycin and gentamicin in urinary tract infections. (1983) (2)
Preliver transplant viremic status and the choice of anti-HBV regimens. (2001) (2)
Tenofovir and HBV mutants after liver transplantation (2003) (2)
Cells of donor phenotype present in renal transplant recipients infused with donor marrow: potent regulators of antidonor immune responses of the recipient. (2001) (2)
Immunosuppression in uterus transplantation: from transplant to delivery (2022) (2)
POLYOMA VIRUS PCR MONITORING IN RENAL TRANSPLANT RECIPIENTS; DETECTION IN BLOOD IS ASSOCIATED WITH HIGHER CREATININE VALUES.: Abstract# 1049 (2000) (2)
The use of pulmonary artery sequestration as an hepatic arterial conduit. A case of unusual hepatic arterial supply. (1989) (2)
Survival of human hepatocellular aggregates in athymic mice. (1992) (2)
Managing liver transplantation during the COVID-19 pandemic: A survey among transplant centers in the Southeast United States (2021) (2)
Liver transplantation at the Miami Transplant Institute: a 14-year single-center experience. (2007) (2)
IMMUNOREGULATION OF BONE MARROW INFUSED LRD RENAL TRANSPLANT RECIPIENTS BY CHIMERIC CELLS OF DONOR PHENOTYPE. (1999) (1)
--------- / 67 7 " HUMAN INTESTINAL AND MUL TIVISCERAL TRANSPLANTATION " Three years clinical experience at the Pittsburgh Transplantation Institute (1)
Isolated intestinal transplantation: A viable option for the treatment of intestinal failure (2001) (1)
Abdominal Wall Transplantation (2008) (1)
Reconstruction of the extrahepatic portal vein after pancreatic trauma – Report of two cases (2013) (1)
196Lamivudine monotherapy in non-viremic HBSAG+liver transplant recipients (2000) (1)
WEANING OF IMMUNOSUPPRESSION IN LONG-TERM LIVER TRANSPLANT RECIPmNTS1,2 (1995) (1)
Use of OKT 3 with Ciclosporin and Steroids for Reversal of Acute Kidney and Liver Allograft Rejection (2010) (1)
Male enterocytes in female intestinal grafts. (2002) (1)
OVERCOMING HBV POST-LIVER TRANSPLANT RECURRENCE: AN ALMOST 5-YEAR EXPERIENCE (1999) (1)
Campath-1H does not alter bone marrow cell regulatory function. (2005) (1)
Clinical xenotransplantation (1994) (1)
INTESTINAL TRANSPLANTATION FOR SHORT GUT SYNDROME SECONDARY TO GASTROSCHISIS (2004) (1)
23-OR: Circulating and graft infiltrating regulatory cells in donor stem cell infused kidney transplant patients (2007) (1)
Histopathological Syndromes of Intestinal Allograft Rejection and Recurrent Disease (2014) (1)
Suitability of neonatal vertebral body marrow for transplant applications. (1995) (1)
SELECTED ORAL COMMUNICATION SESSION, SESSION 44: SURGERY, Tuesday 5 July 2011 15:15 - 16:30 (2011) (1)
Rat enterocyte cultures on human amniotic membranes. (2004) (1)
IVF cycle characteristics in patients approved for uterine transplantation (2018) (1)
Human bone marrow cells retrovirally transduced with the allogeneic class II gene, HLA-DR3β, down regulate anti-allogeneic responses of autologous lymphoid cells (2002) (1)
Differential resistance of the cellular immune responses and immunoregulatory properties of human cadaveric donor bone marrow cells to immunosuppressive drugs commonly used in transplantation. (1998) (1)
Liver Transplantation Following Life-threatening Abdominal Trauma: A Case Series of 5 Patients at a Single Institution. (2019) (1)
346 Long Term Outcomes for Pediatric Patients Transplanted for Autoimmune Hepatitis (2010) (1)
LAMIVUDINE MONOTHERAPY IN NON‐VIREMIC HBSAG+ LIVER TRANSPLANT RECIPIENTS.: Abstract# 777 Poster Board #‐Session: P34‐III (2000) (1)
Parametric Cause-Specific Hazard Modeling with Nonproportional Covariate Effects: A Case Study Using Liver Transplant Data (2010) (1)
Reconstruction of the portal vein during a whipple pancreaticoduodenectomy. (2002) (1)
An Evidence-Based Strategy for HCC Surveillance after Liver Transplantationv: 2177 (2012) (1)
CHIMERISM INDUCTION BY NONMYELOABLATIVE PRECONDITIONING AFTER BONE MARROW INFUSION IN RAT SMALL BOWEL TRANSPLANTATION (1999) (1)
Tacrolimus does not upregulate mucin gene expression after small bowel transplantation in rats. (2003) (1)
INTESTINAL TRANSPLANTATION FOR CHILDREN AT THE UNIVERSITY OF MIAMI ‐ FIVE YEAR EXPERIENCE.: Abstract# 744 Poster Board #‐Session: P1‐III (2000) (1)
Islet transplantation in diabetes: The Pittsburgh experience (1992) (1)
82 Recurrent Hepatocellular Carcinoma After Liver Transplantation in the MELD Era (2010) (1)
Surgical Complications in 275 Human Immunodeficiency Virus (HIV) Infected Liver and/or Kidney Transplant Recipients (2012) (1)
Human intestinal and multivisceral transplantation (1994) (1)
The First Clinical Trial of Uterus Transplantation: Surgical Technique and Outcome (2014) (1)
Cardiac Surgery in Cirrhotic Patients: Should it Be Done Simultaneously or after Liver Transplantation?: 1333 (2012) (1)
CELLULAR PHENOTYPES AFFECTED BY INDUCTION THERAPY WITH CAMPATH-1H VS THYMOGLOBULIN VS ZENAPAX IN KIDNEY ALLOGRAFT RECIPIENTS (2004) (1)
Use of FK 506 in the treatment of liver allograft rejection (1991) (1)
Long Term Outcomes of Auxiliary Partial Orthotopic Liver Transplantation in Pre-Teenage Children With Fulminant Hepatic Failure.: Abstract# D2585 (2014) (1)
Vertebral body procurement from multiorgan donors for bone marrow harvest. (1997) (1)
USE OF SIROLIMUS RESCUE THERAPY IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS WITH TACROLIMUS‐BASED IMMUNOSUPPRESSION.: Abstract# 200 Poster Board #‐Session: P47‐I (2000) (1)
CLINICAL AND IN VITRO SUPPORT FOR IMMUNOREGULATION BY DONOR SPECIFIC BONE MARROW INFUSIONS IN RENAL TRANSPLANTATION (1999) (1)
Treatment of naïve hepatitis C recurrence (HCV-R) in liver transplant recipients with pegylated interferon alpha-2B and ribavirin (2003) (1)
Rescue of acute complete portal vein occlusion with Doppler ultrasound findings after liver transplantation. (2008) (1)
Antigen presentation and immune regulatory capacity of immature and mature dendritic cell enriched antigen presenting cells derived from human bone marrow (2002) (1)
Liver transplantation In patients with situs (2010) (1)
Rejection of human intestinal allografts (1994) (1)
IN SITU QUANTITATIVE IMMUNOPROFILING OF REGULATORY T CELLS USING LASER SCANNING CYTOMETRY: 1192 (2008) (1)
Peripheral Blood Gene Expression Analysis in Small Bowel Transplantation: a Pilot Study to Detect Novel Biomarkers of Graft Rejection: 1719 (2012) (1)
Post-operative care of small bowel transplant recipients (1993) (1)
Demographic characteristics of women with uterine factor infertility seeking information on uterine transplantation (2016) (1)
Progress in liver transplantation. (1988) (1)
Pulmonary Embolism with Bone Fragments following Vertebral Body Marrow Infusion for Tolerance Induction (1996) (1)
The antibody cross match in liver transplantation (2010) (1)
Liver transplantation for primary and secondary hepatic malignancies: radiologic considerations (1991) (1)
92-P Humoral alloimmunity in bowel/multivisceral transplantation – high incidence of sensitization and the significance of a rising donor specific antibody titer in the diagnosis and prognosis of intestinal rejection (2011) (1)
The University of Pittsburgh: a three and three-quarter-year experience with cadaveric renal transplantation under the point system. (1989) (1)
Orthotopic liver transplantation for alpha_x001E_1_x001E_antitrypsin deficiency: An experience in 29 children and ten adults (1987) (1)
Present status of the cluster transplantation and its variants (1991) (1)
Key Ethical Considerations in the Study and Clinical Translation of Uterine Transplantation (2016) (1)
Transplant-associated autoimmune mechanisms in human hepatitis C virus infection (2005) (1)
Testing of a new prototype surgical stapler that automates the rollover sleeve technique for venous anastomoses. (2006) (1)
Evolution of Prevention and Treatment of Post-Liver Transplant HBV Recurrence (1998) (1)
The miracle of liver transplantation (2013) (1)
41 Three cases of septic gas gangrene post-liver transplantation successfully treated with retransplantation (2006) (0)
Intestinal (ITx) and Multivisceral (MVTx) Transplantation after Gastric Bypass for Morbid Obesity: 1646 (2012) (0)
SURGICAL INNOVATION AND POSTOPERATIVE COMPLEXITIES IN LIVER TRANSPLANTATION (2006) (0)
M1019 Alcoholic Liver Disease and Higher Body Mass Index Predict Development of Post Transplant Diabetes Mellitus in Hispanics (2010) (0)
CONVERSION TO ENTERIC-COATED MYCOPHENLATE SODIUM (EC-MPS) FROM MYCOPHENOLATE MOFETIL (MMF) IN STABLE LIVER TRANSPLANT RECIPIENTS – COMPARISON OF PHRAMACOKINETICS (PK) AND GASTROINTESTINAL DISTURBANCES: 357 (2008) (0)
Abdominal Wall Closure in Recipients of Intestinal and Multivisceral Transplants (2013) (0)
Original Contributions Transplantation of Multiple Abdominal Viscera (2010) (0)
Erratum: (The Journal of Clinical Investigation (March 1997) 99:5 (1119)) (1997) (0)
64-P: Pathological features and regulatory cell subpopulations associated with subclinical acute rejection in small intestinal transplantation (2008) (0)
[Transfection with virus interleukin-10 to prolong murine heart allograft]. (2005) (0)
Liver , Kidney , and Thoracic Organ Transplantation (2005) (0)
Devastating Intracardiac and Aortic Thrombosis: A Case Report of Apparent Catastrophic Antiphospholipid Syndrome During Liver Transplantation (2012) (0)
CAMBRIDGE- MIAMI (CAMI) PRE-TRANSPLANT RISK SCORE FOR INTESTINAL AND MULTIVISCERAL TRANSPLANTATION IN ADULTS: 2672 (2010) (0)
Pattern of progression of the MELD score in patients listed for OLT (2003) (0)
O0086 INTESTINAL TRANSPLANTATION FOR CHILDREN-SINGLE CENTER EXPERIENCE OF OVER 100 CHILDREN (2004) (0)
EARLY EXPERIENCE IN AUGMENTING CHIMERISM IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS BY SIMULTANEOUS DONOR BONE MARROW TRANSFUSION (1995) (0)
TREATMENT OF RECURRENT LIVER AUTOIMMUNE DISEASE AFTER TRANSPLANTATION WITH IL‐2 RECEPTOR (DACLIZUMAB).: Abstract# 801 Poster Board #‐Session: P58‐III (2000) (0)
Catastrophic Thromboembolic Disease After Liver Transplantation: Should we Routinely Monitor Coagulation Factors?: 2313 (2017) (0)
Evolution of Gastrointestinal Transplantation at the University of Miami (2001) (0)
Nephrology Dialysis Transplantation Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome (2010) (0)
Human vertebral body procurement from multi-organ donors for bone marrow processing (1996) (0)
CHIMERIC CELLS OF DONOR PHENOTYPE PRESENT IN LIVING RELATED RENAL TRANSPLANT RECIPIENTS INFUSED WITH DONOR MARROW AS POTENT REGULATORS OF RECIPIENT ANTI‐DONOR IMMUNE RESPONSES.: Abstract# 888 Poster Board #‐Session: P145‐III (2000) (0)
O-192 Liver transplantation for patients with hepatic malignancies. (1999) (0)
Small bowel transplantation (2000) (0)
Early clinical experience with cluster resection and transplantation for right upper quadrant abdominal malignancy (1991) (0)
A novel concept of adoptive immunotherapy using interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma. (2011) (0)
IN VITRO REGULATORY ACTIVITY OF B CELLS FROM HUMAN VERTEBRAL BODY BONE MARROW. (1999) (0)
EVOLUTION OF MULTIVISCERAL TRANSPLANTATION — ANALYSIS OF A SINGLE CENTER EXPERIENCE OF 36 CASES.: Abstract# 390 Poster Board #‐Session: P30‐II (2000) (0)
ANALYSIS OF POST-TRANSPLANT IMMUNE STATUS IN RECIPIENTS OF LIVER/BONE MARROW ALLOGRAFTS (1999) (0)
PERIPHERAL BLOOD GENE EXPRESSION ANALYSIS IN SMALL BOWEL TRANSPLANTATION: 2798 (2010) (0)
FOUR YEAR FOLLOW-UP OF HIGH-DOSE DONOR BONE MARROW INFUSIONS TO ENHANCE ALLOGRAFT SURVIVAL (1999) (0)
SF7c-6 Liver transplantation from non-heart-beating donors at the University of Miami (2001) (0)
Auxiliary vascular allografts in renal transplantation (1989) (0)
Graft versus host disease in a rat small bowel transplant model after T-cell depleted donor specific bone marrow infusion (2003) (0)
31 Bone marrow derived mesenchymal stem cells: Impact on neointestinal engineering (2003) (0)
120Recurrent hepatitis C increases the risk of chronic allograft rejection (2000) (0)
Abrogation of the alloreactive responses of cadaver donor intestinal lymphocytes by surgical campath-1H exposure (2003) (0)
Uterus Transplantation: Revisiting the Question of Deceased Donors versus Living Donors for Organ Procurement (2022) (0)
Uterine viability in the baboon following interruption of the uterine arteries and veins bilaterally (2016) (0)
RENOPORTAL ANASTOMOSIS AS AN ALTERNATIVE TO CONVENTIONAL APPROACH FOR THE PORTAL VEIN RECONSTRUCTION. (2006) (0)
49-P : MULTI-SUBSET DONOR LYMPHOID CHIMERISM PATTERNS DURING ACUTE GRAFT VERSUS HOST DISEASE AFTER LIVER TRANSPLANT (2013) (0)
Combined Liver-Islet Allotransplantation (2006) (0)
Uterus Transplantation Model in Sheep with Heterotopic Whole Graft and Anastomosis of Aorta and Cava: 2296 (2012) (0)
CAVAL APPROACH FOR THE SEPARATION OF THE ARTERIS IN MULTI-ORAGAN PROCUREMENT: 1823 (2008) (0)
Reply to "Liver Transplantation and Portal Vein Thrombosis: An Unfinished Saga". (2015) (0)
Prevalence of hla antigens and haplotypes in noncaucasian transplant patients with autoimmune hepatitis (2000) (0)
171-P: Donor:Recipient HLA antigen distribution and the frequency of panel reactive antibodies in small bowel transplanted patients at the University of Miami (2008) (0)
Evaluation of regulatory role of donor chimeric cells present in LRD-renal/bone marrow transplant recipients using a novel CTL microassay (2002) (0)
Analysis of Liver Transplant without Blood Transfusion in Adult Patients: 1360 (2012) (0)
Human dendritic cells treated with inhibitors of NF□B abrogate responses to alloantigen (2004) (0)
Current status on FK 506 in organ transplantation (2010) (0)
Fulminant hepatitis A: Coincidence or a new trend? (1998) (0)
Uterus transplantation: from back table to embryo transfer (2018) (0)
TRANSPLANTATION OF THE STOMACH CLINICOPATHOLOGICAL OUTCOMES REVIEW OF THE GASTRIC ALLOGRAFT INCLUDED IN MULTIVISCERAL GRAFT: 597 (2008) (0)
Retroviral transduction of an allogeneic class II gene into human bone marrow down regulates allo-immune reactivity (2003) (0)
REVERSAL OF GRAFTVERSUSHOST GRAFTVERSUSHOST GRAFTVERSUSHOST VERSUSHOST VERSUSHOST DISEASE WITH INFUSION OF AUTOLOGOUS BONE MARROW (2010) (0)
Post‐Transplant Management (2009) (0)
SINGLE CENTER EXPERIENCE WITH PARTIAL LIVER GRAFTS FOR PEDIATRIC PRIMARY LIVER TRANSPLANTATION: 1897 (2008) (0)
LONG-TERM SURVIVAL OF DONOR-SPECIFIC PANCREATIC ISLET XENOGRAFTS IN FULLY XENOGENEIC CHIMERAS ( WF RAT → B 10 MOUSE ) (2010) (0)
LONG TERM FOLLOW UP OF LIVER TRANSPLANT RECIPIENTS AFTER COMPLETE WITHDRAWAL OF IMMUNOSUPPRESSION: 2017 (2008) (0)
FK 506 in small bowel transplant recipients (1994) (0)
Surgical Technique of Deceased Donor in Uterus Transplantation (2019) (0)
DONOR BONE MARROW, CHIMERISM, AND KIDNEY TRANSPLANTATION. (1998) (0)
INTESTINAL TRANSPLANTATION FOR NECROTIZING ENTEROCOLITIS. (1999) (0)
Table of Contents (2020) (0)
HEPATITIS A: A POTENTIALLY SERIOUS DISEASE. AUTHORS' REPLY (1998) (0)
Impact of Steroids on Natural Killer Cells Against Cytotoxicity and Hepatitis C Virus Replication: 1189 (2012) (0)
A CLINICAL STUDY OF USE OF MICROWAVE COAGULATION THERAPY IN LIVER TRANSPLANT CANDIDATES WITH HEPATOCELLULAR CARCINOMA — A PRELIMINARY REPORT.: Abstract# 392 Poster Board #‐Session: P32‐II (2000) (0)
ENDOSCOPIC ASSESSMENT OF REJECTION IN PEDIATRIC INTESTINAL TRANSPLANT PATIENTS (1998) (0)
Bone marrow–derived mesenchymal cells delay allogeneic rejection (2005) (0)
Chimerism induction by nonmyeloablactive preconditioning and bone marrow infusion in rat small bowel transplantation (2003) (0)
MULTIPLE LIVER RETRANSPLANTATIONS FOR RECURRING HEPATIC GRAFT FAILURE: 2047 (2008) (0)
A Simple Technique for Aortic Cannulation in Organ Donors with Advanced Aortic Disease (2002) (0)
Bone marrow-derived mesenchymal stem cells augment tissue engineered enterocytes (2005) (0)
RECURRENT HEPATITIS C INCREASES THE RISK OF CHRONIC ALLOGRAFT REJECTION.: Abstract# 224 Poster Board #‐Session: P71‐I (2000) (0)
Long‐term Outcomes after Intestinal and Multi‐visceral Transplantation (2014) (0)
LIVER TRANSPLANTATION IN THETREATMENT OF BLEEDING OESOPHAGEAL VARICES (0)
THE IMPACT OF CAMPATH-1H INDUCTION IN ADULT LIVER ALLO-TRANSPLANTATION (2004) (0)
Novel Immunotherapy Using Liver-Derived Natural Killer Cells for Preventing Hepatocellular Carcinoma Recurrence in Liver Transplantation (2016) (0)
10-YEAR EXPERIENCE IN CAVO-PORTAL HEMITRANSPOSITION FOR LIVER TRANSPLANTATION IN THE PRESENCE OF PORTAL VEIN THROMBOSIS. (2006) (0)
USE OF A ZOOM VIDEO ENDOSCOPE FOR THE MONITORING OF REJECTION IN CLINICAL INTESTINAL TRANSPLANTATION (1999) (0)
The Value of Upper Extremity, Face, and Uterus Transplantation: A Summit Conference (2022) (0)
PP-016 Timing referral of patients with intestinal failure – accumulation of preoperative comorbidities adversely affects outcome of subsequent intestinal transplantation (2010) (0)
Medical mystery. (2007) (0)
PP382 Sirolimus(rapamycin) : based rescue treatment for chronic rejection after liver transplant (2001) (0)
Both tissue derived and bone marrow derived stromal cells are immunoregulatory (2004) (0)
Impact of Anti-HCV Therapy and HCV-RNA Titer on Graft Survival after Liver Transplant in Patients with HCV: 1294 (2012) (0)
INCREASED PRODUCTION OF THE REGULATORY T-CELL TRANSCRIPTION FACTOR FOX P-3 M-RNA IN CAMPATH-1H AND DONOR HEMATOPOETIC STEM CELL TREATED KIDNEY TRANSPLANT RECIPIENTS: 379 (2008) (0)
A novel cytokine gene polymorphism PCR-flow assay used to detect chimeric cells in HLA-identical kidney allograft recipients (2005) (0)
TECHNIQUE AND RESULTS OF BILIARY RECONSTRUCTION WITH DUCT-PLASTY IN ORTHOTOPIC LIVER TRANSPLANTS.: 991 (2008) (0)
Pediatric renal transplantation under FK-506 immunosuppression (1993) (0)
Transplantation in Patients with Previous Portasystemic Shunt (2010) (0)
POLYOMA VIRUS IN KIDNEY TRANSPLANT RECIPIENTS: IDENTIFICATION AND MANAGEMENT (2004) (0)
Impact of OKT3 in liver transplantation (1987) (0)
A simple technique for aortic cannulation in organ donors with advanced aortic disease. (2002) (0)
Utilization of Donors with Autoimmune Disorders for Solid Organ Transplantation: 2027 (2012) (0)
Comparison of MELD scores in hepatitis C patients prior to and after adoption of the MELD scoring system (2003) (0)
HUMAN DENDRITIC CELLS TREATED WITH INHIBITORS OF NFKAPPAB ABROGATE RESPONSES TO ALLOANTIGEN VIA INDUCTION OF REGULATORY T CELL POPULATIONS (2004) (0)
Early experience with FK 506 in liver transplantation (1991) (0)
Which liver-disease patients need a transplant? (1988) (0)
EMBRYONIC EVENTS AND NOT UTERINE EVENTS ARE ASSOCIATED WITH PREGNANCY OUTCOMES IN A DECEASED DONOR UTERUS TRANSPLANT PROGRAM: PRELIMINARY RESULTS (2020) (0)
DP-167-8 Influence of liver transplantation on relationship of the spleen and liver, and portosystemic circulation in patients with hypersplenism (2008) (0)
Letters to the Editor Changes in the Antigenicity of a Hepatitis B Virus Mutant Stemming from Lamivudine Therapy (2000) (0)
Recent Advances in Hepatic Transplantation at (1993) (0)
The use of interferon for the treatment of viral hepatitis in pediatric liver transplant recipients. (1995) (0)
Peritoneovenous shunting for the treatment of massive ascites. (1990) (0)
ANALYSIS OF FACTORS AFFECTING EARLY POSTOPERATIVE DOPPLER ULTRASONOGRAPHY AFTER LIVER TRANSPLANTATION (2006) (0)
CAMPATH-1H DOES NOT ALTER DENDRITIC CELL MATURATION, ANTIGEN PRESENTATION, OR BONE MARROW CELL REGULATORY FUNCTION (2004) (0)
ASSESSMENT OF ACUTE REJECTION IN INTESTINAL TRANSPLANT PATIENTS USING A PANEL OF MINIMALLY INVASIVE ASSAYS: 1687 (2008) (0)
TRANSPLANT A TION IN HIV+ P A TIENTS 1 ,2 (1990) (0)
ANTI-DONOR SPECIFIC ANTIBODIES ASSOCIATED WITH ACUTE REJECTION IN THE EARLY POST-TRANSPLANT PERIOD OF SMALL BOWEL AND MULTIVISCERAL ALLOGRAFT RECIPIENTS: 1838 (2010) (0)
GRAFT VERSUS HOST DISEASE (GVHD) IN A RAT SMALL BOWEL TRANSPLANT MODEL AFTER T-CELL DEPLETED DONOR SPECIFIC BONE MARROW (TCD-DSBM) INFUSION. (1999) (0)
Noncomposite simultaneous liver and intestinal transplantation. Authors' reply (2004) (0)
Donor bone marrow infusion augments chimerism in simultaneous pancreas kidney transplantation with OLT3 induction (1996) (0)
Transplantation Proceedings: Preface (2004) (0)
Analysis of intrahepatic biliary strictures without hepatic artery thrombosis in 1113 liver transplantation (2003) (0)
231 EFFECT OF ANTIVIRAL THERAPY ON CELL MEDIATED IMMUNITY IN LIVER TRANSPLANT RECIPIENTS WITH HCV (2012) (0)
ESTABLISHMENT OF A NEW LIVER TRANSPLANT PROGRAM: CHALLENGES DURING THE FIRST 100 CASES.: 2018 (2008) (0)
Single-Center Experience of Post-Transplant Lymphoproliferative Disorder after Liver Transplantation Treated with Immunochemotherapy (2017) (0)
AUXILIARY PARTIAL ORTHOTOPIC LIVER TRANSPLANTATION (APOLT) IN CHILDREN WITH FULMINANT HEPATIC FAILURE: 3043 (2010) (0)
POST KIDNEY TRANSPLANT CMV INCIDENCE IN THE GANCYCLOVIR ERA: MONITORING VIRAL DNA BY A CMV PCR ASSAY (1998) (0)
Tissue chimerism of epithelial and hematopoietic cells, in the allograft of intestinal transplant recipients (2003) (0)
Long-Term Follow-Up of Aortohepatic Conduits in Pediatric Liver Transplantation: 1863 (2012) (0)
Ureteral Reconstruction and Bladder Augmentation Using Intestinal Allograft in a Modified Multivisceral Transplant Patient (2006) (0)
126HBV mutant strains arising after liver transplantation: An insight on the pathogenic potential (2000) (0)
ALTERED EXPRESSION OF CD81 IN HUMAN LIVER ALLOGRAFTS WITH RECURRENT HEPATITIS C INFECTION.: Abstract# 601 (2000) (0)
REDUCED INCIDENCE OF EBV PTLD IN PATIENTS TESTED BY REAL TIME PCR: THE ADJUSTMENT OF IMMUNOSUPRESSION IN RELATION TO AN INDIVIDUALS’ VIRAL LOAD (2004) (0)
Clinical experience with FK 506 (Editorial) (1991) (0)
Future aspects of renal transplantation (1988) (0)
DEVELOPMENT AND REGRESSION OF NEO-INTESTINAL CYSTS IN A RAT MODEL (2004) (0)
TRANSFUSION SUPPORT IN INTESTINAL TRANSPLANTATION: 1690 (2008) (0)
The use of bioloistic particle acelerator to introduce genes into isolated islets of langerhans (1996) (0)
RESCUE OF INTESTINAL FUNCTION IN PATIENTS REFERRED FOR MULTIVISCERAL AND INTESTINAL TRANSPLANTATION: 596 (2008) (0)
KIDNEY TRANSPLANTATION AFTER LIVER TRANSPLANTATION: 1982 (2008) (0)
Liver transplantation in patients with transjugular intrahepatic portosystemic shunt. (1992) (0)
Phenotypic marker and cytotoxic potential of hepatic lymphocytes isolated from rejected livers. (2001) (0)
193: Intestinal tissue engineering: A preliminary study of long term in vitro primary culture of intestinal epithelial cells (2007) (0)
Human Uterus Transplantation Trial: Monitoring, Rejection Episodes and Immunosuppression During 1 Year.: Abstract# 2955 (2014) (0)
IMPACT OF CREG MATCHING AND INCIDENCE OF ANTI-HLA DONOR SPECIFIC ANTIBODY IN TOLERANT LIVER RECIPIENTS AND CONTROLS: 1484 (2008) (0)
73-P: Preliminary Data of PCR-Based Custom Array for Acute Cellular Rejection After Liver Transplantation (2010) (0)
In vivo and in vitro effect of FK 506 on rat Leydig cell function. (1991) (0)
Mechanisms and Possible Management of Hyperacute (Vascular, Humoral) or Xenograft Rejection (1990) (0)
Preiver transplant chemotherapy does not improve survival in HCC prior OLT (1998) (0)
Vascular Diseases of the Liver (2019) (0)
ASSOCIATION BETWEEN ELEVATION OF ANTI-HLA PANEL REACTIVE ANTIBODIES AND EPISODES OF ACUTE SMALL BOWEL REJECTION AFTER INTESTINAL OR MULTIVISCERAL TRANSPLANTATION: 1777 (2010) (0)
THE IMPACT OF CHIMERISM IN CADAVER DONOR LIVER TRANSPLANTATION AND DONOR BONE MARROW INFUSIONS. (2004) (0)
Literature abstracts (2004) (0)
THE CODMAN CLASSIFICATION APPLIED IN LIVER TRANSPLANTATION: A TOOL FOR QUALITY CONTROL AND IMPROVEMENT OF OUTCOMES: 3107 (2010) (0)
PEDIATRIC INTESTINAL TRANSPLANTATION AT THE UNIVERSITY OF MIAMI: 13 YEAR EXPERIENCE: 198 (2008) (0)
Clinical Allograft Rejection Syndromes in Intestinal Transplantation (2014) (0)
155-P: One DRB1 matched living unrelated donor receipients demonstrate better renal function as compared to unmatched living unrelated donor recipients and/or matched cadaveric donor recipients (2007) (0)
CONCURRENT SESSION 41: EVOLVING METHODS OF IMMUNOSUPPRESSION IN LIVER TRANSPLANTATION (2006) (0)
The liver natural killer cells tolerate Alemtuzumab induction therapy in humans (126.3) (2012) (0)
Techniques in intestinal and multivisceral transplantation (2009) (0)
The wide spectrum of sirolimus side effects (2003) (0)
The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence (2011) (0)
Functional analysis of graft lamina propria associated lymphocytes from a recipient of a human cadaveric small bowel allograft primarily immunosuppressed with FK 506. (1991) (0)
CAMPATH-1H (C1H) INDUCTION IN ADULT LIVER TRANSPLANTATION: SIX YEARS EXPERIENCE OF A SINGLE CENTER: 356 (2008) (0)
Operative Procedures Hepatic Artery in Liver Transplantation (2010) (0)
Intestinal transplantation. (1994) (0)
Real time PCR of messenger RNA for transcription factors delineates Th1 activation or Th2 anergy (2002) (0)
Tu1557 – Utility of Sipat Scoring System in Predicting Risk of Recidivism in Patients with Alcoholic Liver Disease (2019) (0)
Liver Grafts Contain a Large Number of CD52 Negative Natural Killer Cells: Role for Infections after Liver Transplantation with Alemtuzumab Induction: 1188 (2012) (0)
Inferior Vena Cava Reconstruction in Liver Transplantation (2017) (0)
Interleukin-6 ) Monitoring in Liver Transplantation Focusmg on Allograft Rejection : A Five-Case Report (2010) (0)
Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy (2022) (0)
SF-016-1 Outcomes of simultaneous liver/kidney transplantation : Miami experience (2011) (0)
Campath-1H Induction in Adult Liver Transplantation: Long-Term Follow Up of 300 Patients: 1615 (2012) (0)
Decreased survival in hepatitis C patients with monomorphic post-transplant lymphoproliferative disorder after liver transplantation treated with frontline immunochemotherapy (2018) (0)
CAMPATH-1H INDUCTION IMMUNOSUPPRESSION IN ADULT NON-HCV LIVER TRANSPLANT RECIPIENTS. EIGHT YEAR EXPERIENCE OF A SINGLE CENTER.: 2556 (2010) (0)
Use of the Recipient Celiac Trunk for Hepatic Artery Reconstruction in Orthotopic Liver Transplant: 976 (2012) (0)
PS-165-6 Conventional Cava Reconstruction without Veno-Venous Bypass in Adult Orthotopic Liver Transplantation (2004) (0)
Rapid development of extensive macrovascular calcifications in a type I diabetic patient. (1991) (0)
Binding of T Cell Depletion Antibody to Natural Killer Cells Leads to Anti-Hepatitis C Effects via Interferon-γ Production: 1192 (2012) (0)
The latest advances in liver transplantation at the pittsburgh transplantation institute: evolution of FK506, liver-intestinal transplantation, clinical xenotransplantation, and the induction of graft acceptance. (1994) (0)
IMPROVEMENT OF SEVERE ACUTE HCV RECURRENCE AFTER OLT WITH &agr;IL‐2R AB (DACLIZUMAB).: Abstract# 595 (2000) (0)
INDUCTION OF T REGULATORY CELLS BY STIMULATION WITH IMMATURE AUTOLOGOUS DENDRITIC CELLS (2004) (0)
Hand-assisted laparoscopic microwave coagulation therapy for hepatocellular carcinoma (2002) (0)
ANTIBODY INDUCTION REGIMENS IN RENAL TRANSPLANT PATIENTS DISPLAY DIFFERENCES IN TOTAL T CELL AND B CELL BUT NOT T-REGULATORY CELL RECOVERY- ASSOCIATION WITH REJECTION AND GRAFT SURVIVAL: 794 (2008) (0)
DETECTION OF CD4+ CELL IMMUNE ACTIVITY IN UTERUS GRAFTED PORCINE PERIPHERAL BLOOD WITH IMMUKNOW ASSAY: 1179 (2008) (0)
Complications of Liver Transplantation (2014) (0)
Improved Outcome In Liver Transplantation For Hepatitis B Under Lamivudine Treatment (1998) (0)
THE SIGNIFICANCE OF HISTOLOGICAL GRADE OF HEPATOCELLULAR CARCINOMA IN THE OUTCOME OF LIVER TRANSPLANTATION.: Abstract# 766 Poster Board #‐Session: P23‐III (2000) (0)
LIVER TRANSPLANTATION IN PATIENTS WITH LIFE SUPPORT: SIGNIFICANT PROGNOSTIC IMPROVEMENT ACHIEVED IN THE PAST DECADE: 2055 (2008) (0)
Abstracts ‐ Monday 23rd July 2001 (2001) (0)
Liver transplantation in HCV-infected patients: An 8 year single center experience (2003) (0)
Effect of Blood Transfusion on Liver Transplant Outcome in Adult Patients: 1349 (2012) (0)
Enhanced cardiac allograft survival by TNFRSF25 expanded natural Treg cells in an allogeneic mouse model (169.9) (2011) (0)
54-P: FRACTIONATED DONOR CHIMERISM (FDC) ANALYSIS IN THE DETECTION AND TREATMENT OF GVHD IN SOLID ORGAN TRANSPLANTATION – DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS (2012) (0)
254: Successful HSCT after multivisceral transplantation (2007) (0)
87 Decrease incidence of CMV infection in liver transplantation with gancyclovir and cytogam prophylaxis (2000) (0)
Multivisceral (cluster) transplants, their spinoffs, and uterine transplants. (2014) (0)
Non-alcoholic fatty liver disease (NAFLD) after orthotopic liver transplantation (OLT) in patients with cryptogenic cirrhosis (CC) and non-alcoholic stestohepatitis (NASH) (2001) (0)
Liver-islet transplantation in type 2 diabetes (1996) (0)
Clinical experience of small bowel/multivisceral transplantation at the University of Miami (2002) (0)
Cadaveric renal transplantation under the American organ allocation system. (1989) (0)
VASCULARIZED STERNUM TRANSPLANTATION AS AN EXPERIMENTAL MODEL IN RAT. (1999) (0)
83-P: Serial cylex- ImmuKnow® testing is beneficial in intestinal transplantation (2009) (0)
FECAL CALPROTECTIN LEVEL IS A SENSITIVE MARKER DETECTING SMALL BOWEL ALLOGRAFT PATHOLOGIES: 202 (2008) (0)
Long Term Follow Up of 30 Operationally Tolerant Liver Transplant Recipients: 1839 (2012) (0)
Uterine viability following interruption of the uterine vein- a pilot study to assess alternative venous return for uterine transplant (2016) (0)
PATHOLOGICAL FEATURES AND REGULATORY CELL SUBPOPULATIONS ASSOCIATED WITH SUBCLINICAL ACUTE REJECTION IN SMALL INTESTINAL TRANSPLANTATION: 201 (2008) (0)
Liver xenotransplantation. (1993) (0)
6. Levi DM, Tzakis AG: Vascular Diseases of the Liver. In: Shackelford's Surgery of the Alimentary (2010) (0)
Uterine and ovarian viability in the baboon with bilateral utero-ovarian microvascular anastomoses alone (2016) (0)
Post-Transplant Lymphoproliferative Disease In Liver Transplant Recipients: A Single Institution Experience (2010) (0)
Factor V Leiden Mutation as a Risk Factor for Hepatic Artery Thrombosis in Liver Transplantation: 1335 (2012) (0)
49-P: Vertebral bone marrow infusions can increase peripheral circulation of “induced” but not “natural” T regulatory cells (Treg) long-term in kidney transplant patients (2007) (0)
New Frontier: Role of the Radiologist in Uterine Transplantation. (2020) (0)
PP356 Strategies for making more organs available for liver yransplantation at UNIV. of MIAMI (2001) (0)
EVOLUTION OF HYPERSPLENISM AFTER LIVER TRANSPLANT: @CT/MRI VOLUMETRY ANALYSIS: 2012 (2008) (0)
LONG‐TERM SURVIVAL OF DONOR‐SPECIFIC PANCREATIC ISLET XENOGRAFTS IN FULLY XENOGENEIC CHIMERAS (WF RAT‐B10 MOUSE) 1, 2 (1992) (0)
Intestinal Transplant in Children with Short Bowel Syndrome of Neonatal Onset: 2029 (2012) (0)
[Clinical experience with FK 506]. (1991) (0)
3445 A clinical study of the use of zoom video endoscopy for the monitoring of acute rejection in the small bowel allograft. (2000) (0)
Sternum transplantation: a novel therapy for aplastic anemia in a rat model. (2001) (0)
Liver Transplantation in Patients with Portal Vein Thrombosis: Improvements and Challenges: 1864 (2012) (0)
Comment on: "The Evolution of Transplantation From Saving Lives to Fertility Treatment, Annals of Surgery (Dallas UtErus Transplant Study), Testa, Giuliano; McKenna, Greg J.; Bayer, Johanna et al.Ann Surg. 2020 Sept; 272(3): 411-417" and related commentary. (2021) (0)
Chimerism diagnosis and outcome in graft versus host disease after orthotopic liver transplantation (1993) (0)
HBV and HCC (2009) (0)
Equipment and method for fixing tightener for anastomosis of hollow organ (1993) (0)
Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease (2003) (0)
PANCREATIC ISLET TRANSPLANTATION. COMMENT. AUTHORS' REPLY (1990) (0)
Characteristics of women with uterine factor infertility seeking information on uterine transplantation (2016) (0)
241: Successful Combined Unrelated Umbilical Cord Blood Haploidentical Transplant in Non Malignant Disease (2008) (0)
127-P: MBL2 Haplotypes in Transplant Patients Are Similar to Other Population Frequencies and Correlate With MBL Protein Levels – Implications for Evaluation of Complement-Mediated Effector Pathway Deficiency in Transplant Recipients (2010) (0)
RETRANSPLANTATION FOR SEVERE REJECTION IN INTESTINAL TRANSPLANT RECIPIENTS.: Abstract# 204 Poster Board #‐Session: P51‐I (2000) (0)
A novel microassay for the evaluation of regulatory cells in human alloreactive CTL responses (2002) (0)
Portosystemic shunting in children with portal hypertension: Its role in the era of endoscopic therapy (1998) (0)
83-P: GVHD IN MVT AND SMALL INTESTINAL TRANPLANTATION HSCT AS SAVAGE THERAPY (2012) (0)
2-OR: Innate and acquired immune responses of graft infiltrating cells in clinical intestinal transplantation (2006) (0)
THE INFLUENCE OF ACUTE REJECTION ON SERUM CITRULLINE LEVELS AMONG RECIPIENTS OF INTESTINAL AND MULTIVISCERAL TRANSPLANT (2004) (0)
SMALL BOWEL ALLOGRAFTS UNDERGOING REJECTION SHOW DISTINCT TRANSCRIPTOME PROFILES IN FORMALIN-FIXED MUCOSAL BIOPSIES: 2465 (2010) (0)
Experience of the University of Pittsburgh, Pittsburgh, Pennsylvania, USA (1989) (0)
EN BLOC LIVER AND KIDNEY TRANSPLANTATION FOR CHILDREN: 1140 (2008) (0)
SF7a-1 Use of Daclizumab in Induction Immunosuppressive Therapy in Clinical Intestinal Transplantation (2000) (0)
Memorial Award of the SGR (1987) (0)
Refractory cirrhotic hydrothorax in end-stage liver disease. The impact of chest tubes on morbidity and mortality (2000) (0)
Detection levels of chimerism in peripheral blood in various organ allograft recipients at the time of rejection (1996) (0)
DETERMINATION OF DONOR SPECIFIC IMMUNE TOLERANCE IN KIDNEY TRANSPLANT PATIENTS WHO HAD RECEIVED PERIOPERATIVE DONOR BONE MARROW CELL INFUSIONS (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Andreas G. Tzakis?

Andreas G. Tzakis is affiliated with the following schools:

Andreas G. Tzakis's Academic­Influence.com Rankings

Why Is Andreas G. Tzakis Influential?

Andreas G. Tzakis's Published Works

Published Works

What Schools Are Affiliated With Andreas G. Tzakis?

Andreas G. Tzakis's AcademicInfluence.com Rankings